<!DOCTYPE html>
<html lang="en" class="scroll-smooth">
<head>
    <meta charset="UTF-8">
    <meta name="viewport" content="width=device-width, initial-scale=1.0">
    <title>Late Night Pyq (Inicet, Medicine-1) - Brain And Scalpel</title>
    <link rel="preload" href="assets/background.jpg" as="image">
    <script src="https://cdn.tailwindcss.com"></script>
    <!-- HLS.js for M3U8 support -->
    <script src="https://cdn.jsdelivr.net/npm/hls.js@latest"></script>
    <style>
        
/* Liquid Glass Morphism Universal Theme - Enhanced & Mobile-First */
:root {
  --glass-bg: rgba(0, 0, 0, 0.6);
  --glass-bg-light: rgba(255, 255, 255, 0.1);
  --glass-bg-medium: rgba(255, 255, 255, 0.15);
  --glass-bg-heavy: rgba(255, 255, 255, 0.2);
  --glass-border: rgba(255, 255, 255, 0.2);
  --glass-border-light: rgba(255, 255, 255, 0.1);
  --text-primary: rgba(255, 255, 255, 0.95);
  --text-secondary: rgba(255, 255, 255, 0.7);
  --text-tertiary: rgba(255, 255, 255, 0.5);
  --accent-blue: #60a5fa;
  --accent-purple: #a855f7;
  --accent-green: #34d399;
  --accent-orange: #fb923c;
  --accent-red: #f87171;
  --accent-yellow: #fbbf24;
}

* {
  margin: 0;
  padding: 0;
  box-sizing: border-box;
}

html {
  scroll-behavior: smooth;
}

body {
  margin: 0;
  min-height: 100vh;
  font-family: system-ui, -apple-system, BlinkMacSystemFont, 'Segoe UI', sans-serif;
  position: relative;
  overflow-x: hidden;
  color: var(--text-primary);
  background-color: #000;
}

/* iOS Background Fix */
body::before {
  content: '';
  position: fixed;
  top: 0;
  left: 0;
  height: 100vh;
  width: 100vw;
  z-index: -2;
  background: url("assets/background.jpg") center center / cover no-repeat;
}

body::after {
  content: "";
  position: fixed;
  inset: 0;
  background: rgba(0, 0, 0, 0.4);
  backdrop-filter: blur(10px);
  -webkit-backdrop-filter: blur(10px);
  z-index: -1;
}

/* Glass morphism components */
.glass {
  background: var(--glass-bg);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-light {
  background: var(--glass-bg-light);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid var(--glass-border-light);
  border-radius: 12px;
}

.glass-medium {
  background: var(--glass-bg-medium);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid var(--glass-border);
  border-radius: 16px;
}

.glass-heavy {
  background: var(--glass-bg-heavy);
  backdrop-filter: blur(25px);
  -webkit-backdrop-filter: blur(25px);
  border: 1px solid var(--glass-border);
  border-radius: 20px;
}

.glass-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.glass-card:hover {
  transform: translateY(-8px);
  background: rgba(255, 255, 255, 0.12);
  border-color: rgba(255, 255, 255, 0.25);
  box-shadow: 0 20px 60px rgba(0, 0, 0, 0.4);
}

.glass-button {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.8), rgba(168, 85, 247, 0.8));
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: white;
  font-weight: 600;
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  box-shadow: 0 4px 20px rgba(96, 165, 250, 0.3);
  cursor: pointer;
  border: none;
}

.glass-button:hover {
  transform: translateY(-2px);
  box-shadow: 0 8px 30px rgba(96, 165, 250, 0.4);
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.9), rgba(168, 85, 247, 0.9));
}

.glass-button:disabled {
  opacity: 0.5;
  cursor: not-allowed;
  transform: none;
}

.glass-input {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(15px);
  -webkit-backdrop-filter: blur(15px);
  border: 1px solid rgba(255, 255, 255, 0.2);
  border-radius: 12px;
  color: var(--text-primary);
  transition: all 0.3s ease;
}

.glass-input:focus {
  outline: none;
  border-color: var(--accent-blue);
  background: rgba(255, 255, 255, 0.12);
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.3);
}

.glass-input::placeholder {
  color: var(--text-tertiary);
}

/* Performance analysis styles */
.performance-card {
  background: rgba(255, 255, 255, 0.08);
  backdrop-filter: blur(20px);
  -webkit-backdrop-filter: blur(20px);
  border: 1px solid rgba(255, 255, 255, 0.15);
  border-radius: 20px;
  box-shadow: 0 8px 32px rgba(0, 0, 0, 0.3);
}

.score-circle {
  position: relative;
  width: 150px;
  height: 150px;
  margin: 0 auto;
}

.score-circle svg {
  transform: rotate(-90deg);
}

.score-circle .circle-bg {
  fill: none;
  stroke: rgba(255, 255, 255, 0.1);
  stroke-width: 8;
}

.score-circle .circle-progress {
  fill: none;
  stroke-width: 8;
  stroke-linecap: round;
  transition: stroke-dasharray 2s cubic-bezier(0.4, 0, 0.2, 1);
}

.score-text {
  position: absolute;
  top: 50%;
  left: 50%;
  transform: translate(-50%, -50%);
  text-align: center;
}

/* Review question styles */
.review-question {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.1);
  border-radius: 16px;
  padding: 20px;
  margin-bottom: 20px;
}

.review-question.correct {
  border-left: 4px solid #22c55e;
}

.review-question.incorrect {
  border-left: 4px solid #ef4444;
}

.review-question.not-attempted {
  border-left: 4px solid #6b7280;
}

/* Gradient backgrounds for accents */
.gradient-blue {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
}

.gradient-purple {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
}

.gradient-green {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
}

.gradient-orange {
  background: linear-gradient(135deg, var(--accent-orange), #f97316);
}

.gradient-red {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
}

.gradient-yellow {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
}

/* Navigation button styles */
.nav-btn-not-attempted {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  color: rgba(255, 255, 255, 0.7);
}

.nav-btn-current {
  background: linear-gradient(135deg, var(--accent-blue), #3b82f6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
  box-shadow: 0 0 20px rgba(96, 165, 250, 0.4);
}

.nav-btn-correct {
  background: linear-gradient(135deg, var(--accent-green), #10b981);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-incorrect {
  background: linear-gradient(135deg, var(--accent-red), #ef4444);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-bookmarked {
  background: linear-gradient(135deg, var(--accent-yellow), #f59e0b);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-marked-review {
  background: linear-gradient(135deg, var(--accent-purple), #8b5cf6);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

.nav-btn-answered {
  background: linear-gradient(135deg, #6b7280, #4b5563);
  border: 1px solid rgba(255, 255, 255, 0.3);
  color: white;
}

/* Option button styles - REVISED FOR INLINE FEEDBACK */
.option-button {
  background: rgba(255, 255, 255, 0.05);
  border: 1px solid rgba(255, 255, 255, 0.15);
  transition: all 0.3s cubic-bezier(0.4, 0, 0.2, 1);
  position: relative;
  overflow: hidden;
  width: 100%;
  text-align: left;
  padding: 1rem;
  border-radius: 12px;
  color: var(--text-primary);
  cursor: pointer;
  display: flex;
  align-items: center;
  gap: 1rem;
  font-size: 1rem;
}

.option-button:hover {
  background: rgba(255, 255, 255, 0.1);
  border-color: rgba(96, 165, 250, 0.5);
  transform: translateX(8px);
}

.option-button.selected {
  background: linear-gradient(135deg, rgba(96, 165, 250, 0.3), rgba(59, 130, 246, 0.3));
  border-color: var(--accent-blue);
  transform: translateX(8px);
}

#optionsContainer.answered .option-button:hover {
    transform: translateX(0); /* Disable hover effect after answering */
}

#optionsContainer.answered .option-button {
    cursor: not-allowed;
    pointer-events: none;
}

#optionsContainer.answered .option-button:not(.correct):not(.incorrect) {
    opacity: 0.5;
}

.option-button.correct {
    background: linear-gradient(135deg, #22c55e, #16a34a);
    border-color: #22c55e;
    color: white;
    transform: translateX(0);
}

.option-button.incorrect {
    background: linear-gradient(135deg, #ef4444, #dc2626);
    border-color: #ef4444;
    color: white;
    transform: translateX(0);
}

.option-letter {
  background: rgba(255, 255, 255, 0.1);
  border: 1px solid rgba(255, 255, 255, 0.2);
  transition: all 0.3s ease;
  width: 2.5rem;
  height: 2.5rem;
  border-radius: 50%;
  display: flex;
  align-items: center;
  justify-content: center;
  font-weight: bold;
  color: var(--text-primary);
  flex-shrink: 0;
}

.option-button.selected .option-letter {
  background: var(--accent-blue);
  border-color: var(--accent-blue);
  color: white;
}

.option-button.correct .option-letter, .option-button.incorrect .option-letter {
    background: rgba(255, 255, 255, 0.2);
    border-color: rgba(255, 255, 255, 0.3);
}

.option-text {
  flex: 1;
  font-size: 1rem;
  line-height: 1.5;
}

/* Stats bar responsive grid */
.stats-grid {
  display: grid;
  grid-template-columns: repeat(5, 1fr);
  gap: 1rem;
  align-items: center;
  justify-items: center;
}

@media (max-width: 768px) {
  .stats-grid {
    grid-template-columns: repeat(3, 1fr);
    gap: 0.5rem;
  }
 
  .stats-grid > div:nth-child(4),
  .stats-grid > div:nth-child(5) {
    grid-column: span 1;
  }
}

@media (max-width: 480px) {
  .stats-grid {
    grid-template-columns: repeat(2, 1fr);
  }
 
  .stats-grid > div:last-child {
    grid-column: span 2;
    justify-self: center;
  }
}

/* Animations */
@keyframes float {
  0%, 100% { transform: translateY(0px); }
  50% { transform: translateY(-20px); }
}

@keyframes pulse-glow {
  0%, 100% { box-shadow: 0 0 20px rgba(96, 165, 250, 0.3); }
  50% { box-shadow: 0 0 40px rgba(96, 165, 250, 0.6); }
}

@keyframes checkmark {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(180deg); }
  100% { transform: scale(1) rotate(360deg); }
}

@keyframes cross {
  0% { transform: scale(0) rotate(0deg); }
  50% { transform: scale(0.8) rotate(90deg); }
  100% { transform: scale(1) rotate(180deg); }
}

.animate-float {
  animation: float 6s ease-in-out infinite;
}

.animate-pulse-glow {
  animation: pulse-glow 2s ease-in-out infinite;
}

.animate-checkmark {
  animation: checkmark 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

.animate-cross {
  animation: cross 0.6s cubic-bezier(0.4, 0, 0.2, 1);
}

/* Custom scrollbar */
::-webkit-scrollbar {
  width: 8px;
}

::-webkit-scrollbar-track {
  background: rgba(255, 255, 255, 0.05);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb {
  background: rgba(255, 255, 255, 0.2);
  border-radius: 4px;
}

::-webkit-scrollbar-thumb:hover {
  background: rgba(255, 255, 255, 0.3);
}

/* --- MOBILE RESPONSIVE STYLES --- */
.quiz-container {
    display: flex;
    flex-direction: column;
    gap: 1.5rem;
}

#mobile-nav-toggle {
    display: none; /* Hidden on desktop */
}

@media (min-width: 1024px) {
    .quiz-container {
        flex-direction: row;
        gap: 2rem;
    }
}

@media (max-width: 1023px) {
    .quiz-sidebar {
        position: fixed;
        top: 0;
        left: 0;
        width: 300px;
        height: 100%;
        z-index: 100;
        transform: translateX(-100%);
        transition: transform 0.3s ease-in-out;
        box-shadow: 10px 0px 30px rgba(0,0,0,0.5);
    }
    .quiz-sidebar.open {
        transform: translateX(0);
    }
    #mobile-nav-toggle {
        display: flex;
        position: fixed;
        bottom: 20px;
        left: 20px;
        z-index: 50;
    }
    .quiz-main-content {
        width: 100%;
    }
}

@media (max-width: 768px) {
    .glass-card, .glass {
        border-radius: 16px;
    }
    h1 { font-size: 2.5rem; }
    #questionText { font-size: 1.125rem; }
    .controls-container {
        flex-direction: column;
        gap: 1rem;
    }
    .controls-container button {
        width: 100%;
    }
}

    </style>
</head>
<body>
    <!-- Mode Selection Modal -->
    <div id="modeModal" class="fixed inset-0 bg-black bg-opacity-70 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-md w-full mx-4 shadow-2xl">
            <h2 class="text-2xl font-bold text-white mb-6 text-center">Choose Study Mode</h2>
            
            <div class="space-y-4">
                <button onclick="selectMode('study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Study Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Interactive learning with immediate feedback</p>
                        </div>
                        <div class="gradient-blue w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 12l2 2 4-4m6 2a9 9 0 11-18 0 9 9 0 0118 0z"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('test')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Test Mode</h3>
                            <p class="text-sm text-white text-opacity-70">Practice test with performance analysis at end</p>
                        </div>
                        <div class="gradient-purple w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path d="M9 2a1 1 0 000 2h2a1 1 0 100-2H9z"></path>
                                <path fill-rule="evenodd" d="M4 5a2 2 0 012-2v1a1 1 0 001 1h6a1 1 0 001-1V3a2 2 0 012 2v6a2 2 0 01-2 2H6a2 2 0 01-2-2V5zm3 4a1 1 0 000 2h.01a1 1 0 100-2H7zm3 0a1 1 0 000 2h3a1 1 0 100-2h-3z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_study')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Study</h3>
                            <p class="text-sm text-white text-opacity-70">Study with time pressure and immediate feedback</p>
                        </div>
                        <div class="gradient-green w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M10 18a8 8 0 100-16 8 8 0 000 16zm1-12a1 1 0 10-2 0v4a1 1 0 00.293.707l2.828 2.829a1 1 0 101.415-1.415L11 9.586V6z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
                
                <button onclick="selectMode('timed_exam')" class="w-full text-left p-4 glass-light hover:bg-white hover:bg-opacity-10 transition-all duration-300 text-white">
                    <div class="flex items-center justify-between">
                        <div>
                            <h3 class="font-semibold">Timed Exam</h3>
                            <p class="text-sm text-white text-opacity-70">Real exam simulation with strict timing</p>
                        </div>
                        <div class="gradient-red w-10 h-10 rounded-lg flex items-center justify-center">
                            <svg class="w-5 h-5 text-white" fill="currentColor" viewBox="0 0 20 20">
                                <path fill-rule="evenodd" d="M12.395 2.553a1 1 0 00-1.45-.385c-.345.23-.614.558-.822.88-.214.33-.403.713-.57 1.116-.334.804-.614 1.768-.84 2.734a31.365 31.365 0 00-.613 3.58 2.64 2.64 0 01-.945-1.067c-.328-.68-.398-1.534-.398-2.654A1 1 0 005.05 6.05 6.981 6.981 0 003 11a7 7 0 1011.95-4.95c-.592-.591-.98-.985-1.348-1.467-.363-.476-.724-1.063-1.207-2.03z" clip-rule="evenodd"></path>
                            </svg>
                        </div>
                    </div>
                </button>
            </div>
        </div>
    </div>

    <!-- Performance Analysis Modal -->
    <div id="performanceModal" class="hidden fixed inset-0 bg-black bg-opacity-80 flex items-center justify-center z-50 backdrop-blur-sm">
        <div class="glass-heavy p-8 max-w-4xl w-full mx-4 shadow-2xl max-h-[90vh] overflow-y-auto">
            <div class="flex items-center justify-between mb-8">
                <h2 class="text-3xl font-bold text-white">Performance Analysis</h2>
                <button onclick="closePerformanceModal()" class="glass-light p-2 rounded-lg text-white hover:bg-white hover:bg-opacity-20">
                    <svg class="w-6 h-6" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M4.293 4.293a1 1 0 011.414 0L10 8.586l4.293-4.293a1 1 0 111.414 1.414L11.414 10l4.293 4.293a1 1 0 01-1.414 1.414L10 11.414l-4.293 4.293a1 1 0 01-1.414-1.414L8.586 10 4.293 5.707a1 1 0 010-1.414z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
            
            <!-- Score Overview -->
            <div class="grid grid-cols-1 md:grid-cols-3 gap-6 mb-8">
                <div class="performance-card p-6 text-center">
                    <div class="score-circle mb-4">
                        <svg width="150" height="150" class="mx-auto">
                            <circle class="circle-bg" cx="75" cy="75" r="65"></circle>
                            <circle id="scoreCircle" class="circle-progress" cx="75" cy="75" r="65" stroke="#22c55e" stroke-dasharray="0 408"></circle>
                        </svg>
                        <div class="score-text">
                            <div class="text-3xl font-bold text-white" id="accuracyScore">0%</div>
                            <div class="text-sm text-white text-opacity-70">Accuracy</div>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Results Summary</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Questions:</span>
                            <span class="text-white font-semibold" id="totalQuestionsResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-green-400">Correct:</span>
                            <span class="text-green-400 font-semibold" id="correctResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-red-400">Incorrect:</span>
                            <span class="text-red-400 font-semibold" id="incorrectResult">0</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-gray-400">Not Attempted:</span>
                            <span class="text-gray-400 font-semibold" id="notAttemptedResult">0</span>
                        </div>
                    </div>
                </div>
                
                <div class="performance-card p-6">
                    <h3 class="text-lg font-bold text-white mb-4 text-center">Time Analysis</h3>
                    <div class="space-y-3">
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Total Time:</span>
                            <span class="text-white font-semibold" id="totalTimeResult">0:00</span>
                        </div>
                        <div class="flex justify-between items-center">
                            <span class="text-white text-opacity-70">Avg per Question:</span>
                            <span class="text-white font-semibold" id="avgTimeResult">0:00</span>
                        </div>
                    </div>
                </div>
            </div>
            
            <!-- Action Buttons -->
            <div class="flex justify-center space-x-4 mb-8">
                <button onclick="reviewQuestions()" class="glass-button px-8 py-3 text-lg">
                    Review All Questions
                </button>
                <button onclick="retakeQuiz()" class="glass-light px-8 py-3 text-lg text-white hover:bg-white hover:bg-opacity-20">
                    Retake Quiz
                </button>
            </div>
            
            <!-- Question Review Section -->
            <div id="questionReviewSection" class="hidden">
                <h3 class="text-2xl font-bold text-white mb-6">Question Review</h3>
                <div id="reviewQuestionsContainer">
                    <!-- Review questions will be populated here -->
                </div>
            </div>
        </div>
    </div>

    <!-- Header -->
    <header class="glass sticky top-0 z-40 mb-6">
        <div class="container mx-auto px-6 py-4">
            <div class="flex items-center justify-between">
                <div class="flex items-center space-x-4">
                    <button onclick="goBack()" class="glass-light px-4 py-2 text-white hover:bg-white hover:bg-opacity-20 transition-all duration-300 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M9.707 16.707a1 1 0 01-1.414 0l-6-6a1 1 0 010-1.414l6-6a1 1 0 011.414 1.414L5.414 9H17a1 1 0 110 2H5.414l4.293 4.293a1 1 0 010 1.414z" clip-rule="evenodd"></path>
                        </svg>
                        Back
                    </button>
                    <div id="quizHierarchy" class="text-sm text-white text-opacity-60">
                        Cerebellum / Mock Test / Late Nighgt PYQ (INICET)
                    </div>
                </div>
                
                <div class="flex items-center space-x-4">
                    <div class="glass-light px-3 py-1 text-sm text-white">
                        Question <span id="currentQuestion">1</span> of <span id="totalQuestions">75</span>
                    </div>
                    
                    <!-- Timer -->
                    <div id="timerContainer" class="hidden gradient-red px-3 py-1 text-sm text-white font-bold animate-pulse-glow">
                        <span id="timeDisplay">2:00</span>
                    </div>
                </div>
            </div>
        </div>
    </header>

    <!-- Progress Bar -->
    <div class="w-full h-1 bg-black bg-opacity-30 mb-6">
        <div id="progressBar" class="h-1 gradient-blue transition-all duration-500 ease-out" style="width: 0%"></div>
    </div>

    <!-- Stats Bar - Show only in study modes -->
    <div id="statsBar" class="glass-light mb-8">
        <div class="container mx-auto px-6 py-4">
            <div class="stats-grid">
                <div class="text-center">
                    <div class="text-lg font-bold text-green-400" id="correctCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Correct</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-red-400" id="incorrectCount">0</div>
                    <div class="text-xs text-white text-opacity-60">Incorrect</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-blue-400" id="totalAttempted">0</div>
                    <div class="text-xs text-white text-opacity-60">Attempted</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-purple-400" id="accuracy">0%</div>
                    <div class="text-xs text-white text-opacity-60">Accuracy</div>
                </div>
                <div class="text-center">
                    <div class="text-lg font-bold text-orange-400" id="timeSpent">0:00</div>
                    <div class="text-xs text-white text-opacity-60">Time</div>
                </div>
            </div>
        </div>
    </div>

    <div class="quiz-container container mx-auto px-6">
        <!-- Question Navigation Sidebar -->
        <div id="quizSidebar" class="quiz-sidebar glass p-6 h-fit lg:sticky top-24">
            <h3 class="text-lg font-bold text-white mb-4">Question Navigator</h3>
            <div id="questionNav" class="grid grid-cols-5 gap-2 mb-6">
                <!-- Question numbers will be populated here -->
            </div>
            
            <div class="space-y-3 text-xs">
                <h4 class="text-sm font-medium text-white text-opacity-80 mb-3">Legend</h4>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-not-attempted rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Not Attempted</span>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-current rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Current</span>
                </div>
                <div id="studyModeLegend" class="space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-correct rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Correct</span>
                    </div>
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-incorrect rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Incorrect</span>
                    </div>
                </div>
                <div id="testModeLegend" class="hidden space-y-2">
                    <div class="flex items-center">
                        <div class="w-6 h-6 nav-btn-answered rounded mr-2"></div>
                        <span class="text-white text-opacity-60">Answered</span>
                    </div>
                </div>
                <div class="flex items-center">
                    <div class="w-6 h-6 nav-btn-bookmarked rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Bookmarked</span>
                </div>
                <div id="testModeReviewLegend" class="hidden items-center">
                    <div class="w-6 h-6 nav-btn-marked-review rounded mr-2"></div>
                    <span class="text-white text-opacity-60">Marked for Review</span>
                </div>
            </div>
            
            <!-- Submit Quiz Button for test modes -->
            <div id="submitSection" class="hidden mt-6">
                <button onclick="submitQuiz()" class="glass-button w-full py-3 text-lg font-bold">
                    Submit Quiz
                </button>
            </div>
        </div>

        <!-- Main Quiz Interface -->
        <div class="quiz-main-content flex-1 max-w-4xl">
            <div class="glass-card p-4 md:p-8 lg:p-12 mb-8 relative">
                <!-- Question Text -->
                <div id="questionText" class="text-xl lg:text-2xl leading-relaxed text-white mb-8">
                    Loading question...
                </div>

                <!-- Question Media -->
                <div id="questionMedia" class="mb-8"></div>

                <!-- Options -->
                <div id="optionsContainer" class="space-y-3 mb-8">
                    <!-- Options will be inserted here -->
                </div>

                <!-- Solution Display (only for study modes) -->
                <div id="solutionContainer" class="hidden glass-light p-6 border-l-4 border-green-400">
                    <h3 class="text-lg font-bold text-green-400 mb-3 flex items-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                            <path fill-rule="evenodd" d="M18 10a8 8 0 11-16 0 8 8 0 0116 0zm-7-4a1 1 0 11-2 0 1 1 0 012 0zM9 9a1 1 0 000 2v3a1 1 0 001 1h1a1 1 0 100-2v-3a1 1 0 00-1-1H9z" clip-rule="evenodd"></path>
                        </svg>
                        Explanation
                    </h3>
                    <div id="solutionText" class="text-white text-opacity-90 leading-relaxed mb-4"></div>
                    <div id="solutionAudio" class="space-y-2 mt-4"></div>
                    <div id="solutionImages" class="space-y-4 mt-4"></div>
                    <div id="solutionVideo" class="hidden mt-4">
                        <video id="explanationVideoPlayer" class="w-full rounded-lg" controls>
                            Your browser does not support the video tag.
                        </video>
                    </div>
                </div>
            </div>

            <!-- Controls -->
            <div class="controls-container flex justify-between items-center mb-8">
                <button onclick="previousQuestion()" id="prevBtn" class="glass-button px-6 py-3 flex items-center justify-center disabled:opacity-50 disabled:cursor-not-allowed">
                    <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M12.707 5.293a1 1 0 010 1.414L9.414 10l3.293 3.293a1 1 0 01-1.414 1.414l-4-4a1 1 0 010-1.414l4-4a1 1 0 011.414 0z" clip-rule="evenodd"></path>
                    </svg>
                    Previous
                </button>
                
                <div class="flex justify-center flex-grow">
                    <button onclick="toggleBookmark()" id="bookmarkBtn" class="glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" id="bookmarkIcon" fill="currentColor" viewBox="0 0 20 20">
                            <path d="M5 4a2 2 0 012-2h6a2 2 0 012 2v14l-5-2.5L5 18V4z"></path>
                        </svg>
                        <span id="bookmarkText">Bookmark</span>
                    </button>
                    
                    <button onclick="toggleMarkForReview()" id="markReviewBtn" class="hidden glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center justify-center">
                        <svg class="w-5 h-5 mr-2" fill="currentColor" viewBox="0 0 20 20">
                           <path fill-rule="evenodd" d="M5 2a2 2 0 00-2 2v12a2 2 0 002 2h10a2 2 0 002-2V4a2 2 0 00-2-2H5zm0 2h10v12H5V4z" clip-rule="evenodd" />
                           <path d="M12.586 6.586a2 2 0 10-2.828 2.828l-3 3a2 2 0 102.828-2.828l3-3z" />
                        </svg>
                        <span id="markReviewText">Mark for Review</span>
                    </button>
                </div>
                
                <button onclick="nextQuestion()" class="glass-button px-6 py-3 flex items-center justify-center">
                    Next
                    <svg class="w-5 h-5 ml-2" fill="currentColor" viewBox="0 0 20 20">
                        <path fill-rule="evenodd" d="M7.293 14.707a1 1 0 010-1.414L10.586 10 7.293 6.707a1 1 0 011.414-1.414l4 4a1 1 0 010 1.414l-4 4a1 1 0 01-1.414 0z" clip-rule="evenodd"></path>
                    </svg>
                </button>
            </div>
        </div>
    </div>

     <!-- Mobile Nav Toggle -->
    <button id="mobile-nav-toggle" onclick="toggleSidebar()" class="glass-button w-14 h-14 rounded-full items-center justify-center">
        <svg class="w-6 h-6 text-white" fill="none" stroke="currentColor" viewBox="0 0 24 24"><path stroke-linecap="round" stroke-linejoin="round" stroke-width="2" d="M4 6h16M4 12h16M4 18h16"></path></svg>
    </button>


    <script>
        let questionsData = [
  {
    "id": 11753,
    "choices": [
      {
        "id": 46978,
        "text": "<p><span style=\"font-size:12.0pt;\">DC Cardioversion</span></p>"
      },
      {
        "id": 46979,
        "text": "<p><span style=\"font-size:12.0pt;\">Valsalva Maneuver</span></p>"
      },
      {
        "id": 46980,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
      },
      {
        "id": 46981,
        "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient comes with palpitation to ER. His Pulse-180/min and BP-70mm of Hg systolic. ECG shows narrow QRS complex tachycardia with regular heart rate. What is the next step in management? (INICET NOV 2020)</span></p>",
    "unique_key": "Q9204954",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066849,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;DC cardioversion</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For a patient presenting with hemodynamically unstable symptoms such as a significantly low blood pressure and a high heart rate, as indicated by a pulse of 180/min and systolic BP of 70 mmHg, immediate DC cardioversion is indicated. This procedure is critical for restoring normal heart rhythm and preventing further cardiovascular compromise.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Valsalva Maneuver: </strong>it&nbsp;is typically used in stable patients to attempt cardioversion of supraventricular tachycardia (SVT) back to a normal rhythm. It is not suitable for patients showing signs of hemodynamic instability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adenosine: </strong>it&nbsp;is effective in terminating certain types of SVT by temporarily blocking the AV node but is used in stable patients. Given the patient's low BP, this is not the first-line approach.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Verapamil:&nbsp;</strong>it&nbsp;is a calcium channel blocker used for rate control in cases of SVT, more appropriate for stable patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">DC cardioversion is the emergency treatment of choice for a patient with hemodynamically unstable narrow QRS complex tachycardia, as it quickly restores normal rhythm and stabilizes the patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21/Cardiology/SVT/chap 246</strong></span></p>",
    "correct_choice_id": 46978,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11698,
    "choices": [
      {
        "id": 46758,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tip of nose to ear to xiphisternum</span></span></span></span></p>"
      },
      {
        "id": 46759,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Tip of nose to angle of ear to umbilicus </span></span></span></span></p>"
      },
      {
        "id": 46760,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mouth to ear to umbilicus</span></span></span></span></p>"
      },
      {
        "id": 46761,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mouth to ear to midway between xiphisternum and umbilicus</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">As an intern in emergency ward, which of the following method would you consider as correct regarding nasogastric tube length estimation? (AIIMS NOV 2018)</span></span></span></span></p>",
    "unique_key": "Q7695323",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066806,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Tip of nose to ear to xiphisternum (i.e., N-E-X)</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Approximate length of nasogastric tube is 120 -125cm&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">How to confirm correct position of NG tube: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Auscultation in the epigastric area while injecting a bolus of air</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">x-ray chest</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Colorimetric capnography </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm113.jpg\" style=\"height:713px; width:562px\" /></p>\r\n\r\n<p style=\"margin-left:240px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:240px\"><span style=\"font-size:9pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"color:#44546a\"><em><strong><span dir=\"ltr\" lang=\"EN-GB\" style=\"color:#0d0d0d\">XIPHISTERNUM</span></strong></em></span></span></span></p>\r\n\r\n<p style=\"margin-left:240px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\">Place the tip of the nasogastric tube at the tip of the nose, then measure from the nose to the ear lobe &amp; down to the tip of the Xiphisternum</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Tip of nose to angle of ear to umbilicus:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This measurement is too long as it typically extends beyond the stomach, potentially reaching into the intestines.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Mouth to ear to umbilicus:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This measurement is also incorrect and typically used for other medical estimations, not for NG tube placement.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Mouth to ear to midway between xiphisternum and umbilicus:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Similar to option B, this measurement is excessively long for proper NG tube placement.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">When inserting a nasogastric tube, the correct measurement to estimate the necessary tube length is from the tip of the nose to the earlobe to the xiphisternum, ensuring the tube reaches the stomach properly for effective therapeutic or diagnostic use.</span></span></span></span></p>",
    "correct_choice_id": 46758,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "InstrumentsBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11655,
    "choices": [
      {
        "id": 46586,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Digoxin</span></span></span></span></p>"
      },
      {
        "id": 46587,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Spironolactone</span></span></span></span></p>"
      },
      {
        "id": 46588,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Enalapril</span></span></span></span></p>"
      },
      {
        "id": 46589,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Furosemide</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">A 45-year-old female patient has NYHA class III heart failure, with dyspnea, pedal edema and K+ levels of 5.5mg% and creatinine 1.1 mg%. Which of the following drugs can be used in this patient?</span></span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> (AIIMS NOV 2017)</span></span></span></p>",
    "unique_key": "Q3819762",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066789,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Ans. D) Furosemide</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Furosemide can be used in this patient. All the other drugs mentioned are avoided due to the risk of hyperkalemia. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Beta &ndash; blockers- interferes with beta 2 mediated intracellular potassium uptake. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">ACE Inhibitors- inhibition of angiotensin II formation with a decrease in aldosterone secretion. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"color:black\">Angiotensin II receptors blockers (ARBS)- block AT1 receptor, decreasing in aldosterone.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/10/screenshot-2024-09-10-145106.png\" style=\"height:213px; width:1000px\" /></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Digoxin:</span></strong><span style=\"font-size:12.0pt\"> Typically avoided if there&#39;s a risk of hyperkalemia, as it can be dangerous in elevated potassium levels, potentially causing cardiac arrhythmias.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Spironolactone:</span></strong><span style=\"font-size:12.0pt\"> Being a potassium-sparing diuretic, it is contraindicated in patients with high serum potassium levels as it could exacerbate hyperkalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Enalapril:</span></strong><span style=\"font-size:12.0pt\"> As an ACE inhibitor, it can increase potassium levels by reducing aldosterone secretion, thus inappropriate for patients already presenting with hyperkalemia.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In heart failure patients with elevated potassium levels, loop diuretics like furosemide are preferred to manage fluid overload and avoid exacerbation of hyperkalemia, unlike potassium-sparing diuretics or ACE inhibitors.</span></span></span></p>",
    "correct_choice_id": 46589,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11523,
    "choices": [
      {
        "id": 46058,
        "text": "<p><span style=\"font-size:12.0pt;\">MS</span></p>"
      },
      {
        "id": 46059,
        "text": "<p><span style=\"font-size:12.0pt;\">ALS</span></p>"
      },
      {
        "id": 46060,
        "text": "<p><span style=\"font-size:12.0pt;\">GBS</span></p>"
      },
      {
        "id": 46061,
        "text": "<p><span style=\"font-size:12.0pt;\">Tropical spastic paraparesis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 45-year-old male patient presented with a history of bilateral lower limb weakness which progressed to his upper limbs in a year. On examination, he had weakness in both lower limbs and wasting in the left upper limb. Babinski sign was positive and the deep tendon reflexes were absent. He has no sensory loss or any autonomic dysfunction. What is the likely diagnosis? (INICET MAY 2021)</span></p>",
    "unique_key": "Q1822582",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066785,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) ALS</strong></span></p><p><br><span style=\"font-size:12pt;\">Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by mixed upper and lower motor neuron signs. The presence of both Babinski sign (an upper motor neuron sign) and absent deep tendon reflexes (a lower motor neuron sign), along with the chronic progression and lack of sensory/autonomic involvement, strongly points towards ALS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12pt;\"><strong>Option A. MS:</strong> Multiple sclerosis typically involves sensory symptoms and demyelinating plaques visible on MRI, which are not described here.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. GBS:</strong> Guillain-Barr\u00e9 Syndrome is an acute condition with a rapid onset and is primarily a lower motor neuron disease without upper motor neuron signs like the Babinski reflex.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Tropical spastic paraparesis:</strong> This condition is associated with HTLV-1 infection and presents predominantly with upper motor neuron signs, not the mixed signs seen in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">ALS presents with both upper and lower motor neuron signs, progressive weakness, and no sensory or autonomic dysfunction.</span></p>",
    "correct_choice_id": 46059,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11707,
    "choices": [
      {
        "id": 46794,
        "text": "<p><span style=\"font-size:12.0pt;\">Proximal RTA</span></p>"
      },
      {
        "id": 46795,
        "text": "<p><span style=\"font-size:12.0pt;\">Pancreatitis</span></p>"
      },
      {
        "id": 46796,
        "text": "<p><span style=\"font-size:12.0pt;\">Severe diarrhea</span></p>"
      },
      {
        "id": 46797,
        "text": "<p><span style=\"font-size:12.0pt;\">Salicylate poisoning</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis with normal anion gap is seen in all except? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q2286027",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066815,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Salicylate poisoning.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metabolic acidosis can present with either a normal or elevated anion gap. Salicylate poisoning characteristically causes a high anion gap metabolic acidosis due to the accumulation of organic acids like lactic acid and ketoacids. It can initially present with a respiratory alkalosis due to direct stimulation of the respiratory center, followed by metabolic acidosis as the condition progresses.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Proximal RTA (Renal Tubular Acidosis):&nbsp;</strong>This causes a normal anion gap (hyperchloremic) metabolic acidosis due to bicarbonate loss in the urine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pancreatitis:&nbsp;</strong>Can lead to normal anion gap acidosis if associated with diarrhea or other mechanisms leading to bicarbonate loss.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Severe diarrhea:&nbsp;</strong>Leads to normal anion gap metabolic acidosis due to significant loss of bicarbonate in stool.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/10/screenshot-2024-09-10-161817.png\" alt=\"\" width=\"1000\" height=\"467\"></p>",
    "correct_choice_id": 46797,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11678,
    "choices": [
      {
        "id": 46678,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12.0pt;\">Dysphagia</span></p>"
      },
      {
        "id": 46679,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12.0pt;\">Spasticity</span></p>"
      },
      {
        "id": 46680,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12.0pt;\">Fever</span></p>"
      },
      {
        "id": 46681,
        "text": "<p style=\"margin-left:4px;\"><span style=\"font-size:12.0pt;\">Neglect</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following features of stroke need not be treated? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q5716399",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066799,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Neglect</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Neglect after a stroke, often presenting as a lack of awareness of one side of the body, does not typically require direct medical treatment. While it may indicate a more severe stroke and can impact rehabilitation, many patients improve as they recover from other stroke symptoms. Therapy focuses on aiding patients in adapting to or compensating for this deficit.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Dysphagia:</strong> Must be treated to prevent complications like aspiration pneumonia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Spasticity:</strong> Requires management with medications (baclofen, tizanidine) or physical therapy to improve mobility and reduce discomfort.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Fever:</strong> Should be treated promptly as it can exacerbate brain injury and worsen outcomes in stroke patients.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While neglect is a common symptom following a stroke, it does not typically require specific medical treatment but rather supportive care and rehabilitation to help the patient adapt. Other physical symptoms such as dysphagia, spasticity, and fever require active medical management to prevent complications.</span></p>",
    "correct_choice_id": 46681,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11584,
    "choices": [
      {
        "id": 46302,
        "text": "<p><span style=\"font-size:12.0pt;\">Diazepam</span></p>"
      },
      {
        "id": 46303,
        "text": "<p><span style=\"font-size:12.0pt;\">Alprazolam</span></p>"
      },
      {
        "id": 46304,
        "text": "<p><span style=\"font-size:12.0pt;\">Clonazepam</span></p>"
      },
      {
        "id": 46305,
        "text": "<p><span style=\"font-size:12.0pt;\">Lorazepam</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 40-year-old chronic alcoholic presented with withdrawal symptoms. His liver function tests showed:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">AST 140 IU/L,</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">ALT 110 IU/L, and</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">GGT 500 IU/L.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Which of the following benzodiazepines can be safely administered to this patient? </span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
    "unique_key": "Q8331787",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066820,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>D) Lorazepam</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's liver function tests indicate elevated liver enzymes (AST, ALT, and GGT), suggesting potential alcoholic hepatitis or liver impairment. In such cases, choosing the appropriate benzodiazepine is crucial due to the liver's role in drug metabolism.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Lorazepam is a preferred benzodiazepine in patients with liver impairment for the following reasons:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Short-acting</strong>: Lorazepam is a short-acting benzodiazepine, which means it has a shorter half-life and less risk of accumulation in the body compared to long-acting benzodiazepines.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Minimal liver metabolism</strong>: Lorazepam undergoes minimal hepatic metabolism, which makes it safer for patients with impaired liver function. This reduces the risk of adverse effects and toxicity.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Diazepam:</strong> Diazepam is a long-acting benzodiazepine. It undergoes extensive hepatic metabolism, leading to active metabolites that can accumulate, especially in patients with liver dysfunction. This increases the risk of prolonged sedation and toxicity.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Alprazolam:</strong> Alprazolam, although shorter-acting than diazepam, still undergoes significant liver metabolism. It is not as safe as lorazepam in patients with compromised liver function.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Clonazepam</strong>: Clonazepam is also a long-acting benzodiazepine with extensive hepatic metabolism. Like diazepam, its use in patients with liver impairment can lead to accumulation and increased risk of side effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In patients with liver impairment, such as those with alcoholic hepatitis, lorazepam is the preferred benzodiazepine due to its short-acting nature and minimal hepatic metabolism.</span></p>",
    "correct_choice_id": 46305,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11740,
    "choices": [
      {
        "id": 46926,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chronic respiratory acidosis, acute metabolic alkalosis</span></span></span></span></p>"
      },
      {
        "id": 46927,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute respiratory acidosis, acute respiratory alkalosis</span></span></span></span></p>"
      },
      {
        "id": 46928,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute Metabolic alkalosis, acute respiratory acidosis</span></span></span></span></p>"
      },
      {
        "id": 46929,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute respiratory acidosis, acute metabolic alkalosis</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the areas marked F, C in the following diagram: (INICET NOV 2020)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm124.jpg\" style=\"height:306px; width:300px\" /></span></span></span></span></p>",
    "unique_key": "Q1505377",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066846,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Acute respiratory acidosis, acute respiratory alkalosis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area F</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Positioned in the lower left part of the diagram, which corresponds to higher PCO2 and a pH less than 7.35. This area represents <strong>Acute Respiratory Acidosis</strong> due to an increase in CO2, causing a drop in blood pH.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Area C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Positioned in the upper right part of the diagram, which corresponds to lower PCO2 and a pH greater than 7.45. This area represents <strong>Acute Respiratory Alkalosis</strong> caused by a decrease in CO2, increasing blood pH.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm125.jpg\" style=\"height:507px; width:496px\" /></span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Understanding the relationship between pH, bicarbonate (HCO3-), and CO2 is crucial for interpreting arterial blood gases. Area F indicates acute respiratory acidosis due to increased CO2, and area C indicates acute respiratory alkalosis due to decreased CO2.</span></span></span></span></p>",
    "correct_choice_id": 46927,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11607,
    "choices": [
      {
        "id": 46394,
        "text": "<p><span style=\"font-size:12.0pt;\">Guillain-Barre syndrome</span></p>"
      },
      {
        "id": 46395,
        "text": "<p><span style=\"font-size:12.0pt;\">Spinal muscular atrophy</span></p>"
      },
      {
        "id": 46396,
        "text": "<p><span style=\"font-size:12.0pt;\">Duchenne muscular dystrophy</span></p>"
      },
      {
        "id": 46397,
        "text": "<p><span style=\"font-size:12.0pt;\">Myasthenia gravis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Tongue fasciculations are seen in:</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
    "unique_key": "Q4467732",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066842,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) Spinal muscular atrophy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tongue fasciculations are indicative of a lower motor neuron lesion, often associated with disorders that affect the anterior horn cells in the spinal cord or the motor neurons in the brainstem.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Spinal muscular atrophy (SMA):</strong> This condition is characterized by the degeneration of anterior horn cells in the spinal cord and motor nuclei in the lower brainstem. This degeneration leads to muscle weakness and atrophy, including the muscles of the tongue, resulting in tongue fasciculations. SMA is divided into several types based on the age of onset and severity, but fasciculations are a common feature across these types.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Guillain-Barre syndrome:</strong> This is an acute inflammatory demyelinating polyneuropathy that primarily affects the peripheral nerves. It does not typically cause fasciculations, as it is more associated with rapidly progressive weakness and areflexia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Duchenne muscular dystrophy:</strong> This is a genetic disorder characterized by progressive muscle degeneration and weakness. It primarily affects the skeletal muscles, and while it leads to muscle weakness, it does not typically cause fasciculations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Myasthenia gravis:</strong> This is an autoimmune disorder affecting the neuromuscular junction. It leads to fluctuating muscle weakness and fatigability but does not involve lower motor neurons or cause fasciculations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Tongue fasciculations are a clinical sign associated with spinal muscular atrophy due to the involvement of lower motor neurons</span></p>",
    "correct_choice_id": 46395,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11566,
    "choices": [
      {
        "id": 46230,
        "text": "<p><span style=\"font-size:12.0pt;\">CT angiography to look for large vessel occlusion</span></p>"
      },
      {
        "id": 46231,
        "text": "<p><span style=\"font-size:12.0pt;\">MRI to look for infarct</span></p>"
      },
      {
        "id": 46232,
        "text": "<p><span style=\"font-size:12.0pt;\">Tab labetalol 10 mg stat</span></p>"
      },
      {
        "id": 46233,
        "text": "<p><span style=\"font-size:12.0pt;\">Thrombolysis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 50-year-old man suddenly developed right-sided weakness and aphasia within 2 hours. His BP recorded was 160/110 mmHg and NCCT was clear. What is the next step in management? (INICET MAY 2021)</span></p>",
    "unique_key": "Q1284812",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066803,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;D) Thrombolysis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">With a BP below 185/110 mmHg, clear NCCT, and symptoms within 4.5 hours, the patient qualifies for thrombolysis, the standard treatment for acute ischemic stroke to dissolve clots and restore blood flow.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">If the blood pressure (BP) is more than or equal to 185/110 mmHg, administer IV labetalol to lower the BP to less than 185/110 mmHg before immediately proceeding with thrombolysis. CT angiography can be performed while thrombolysis is ongoing. Start the thrombolytic agent in the CT room and simultaneously inject a bolus of contrast for the CT angiogram to check for large vessel occlusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. CT angiography:&nbsp;</strong>CT angiography can be done simultaneously with thrombolysis but not instead of it.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. MRI:&nbsp;</strong>MRI is not the immediate next step when NCCT is clear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Labetalol:&nbsp;</strong>Labetalol is used to lower BP but not the primary treatment in this context.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12pt;\">In acute ischemic stroke with BP &lt; 185/110 and clear NCCT, thrombolysis is the next step.</span></p>",
    "correct_choice_id": 46233,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11737,
    "choices": [
      {
        "id": 46914,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Bilirubin</span></span></span></span></p>"
      },
      {
        "id": 46915,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin</span></span></span></span></p>"
      },
      {
        "id": 46916,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Prothrombin time</span></span></span></span></p>"
      },
      {
        "id": 46917,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Creatinine</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Components of the MELD (2016) score are all except? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q1192876",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066843,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The Model for End-Stage Liver Disease (MELD) score is used to prioritize patients for liver transplantation and assesses the severity of chronic liver disease. The MELD score includes three laboratory values:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&ldquo;CBI mnemonic = Creatinine, Bilirubin, INR are the parameters is MELD score.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Currently Sodium levels to the score and MELD-Na score used for prognostication. Hyponatremia associated with adverse outcomes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;<strong>Bilirubin:</strong> Reflects the liver&#39;s ability to excrete bilirubin.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>INR (International Normalized Ratio) for prothrombin time:</strong> Indicates the liver&#39;s ability to synthesize clotting factors.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Creatinine:</strong> Assesses renal function, which can be compromised in liver failure. Additionally, sodium was added to the MELD score to improve its prognostic accuracy, resulting in the MELD-Na score.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Albumin is not a component of the MELD score. The key components are bilirubin, creatinine, and INR, with sodium also included in the updated MELD-Na scoring system to better predict outcomes in patients with end-stage liver disease.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference: Harrison 21/Cirrhosis/Chap 344</span></span></strong></span></span></p>",
    "correct_choice_id": 46915,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11533,
    "choices": [
      {
        "id": 46098,
        "text": "<p><span style=\"font-size:12.0pt;\">Fixed distal airway obstruction</span></p>"
      },
      {
        "id": 46099,
        "text": "<p><span style=\"font-size:12.0pt;\">Fixed central airway obstruction</span></p>"
      },
      {
        "id": 46100,
        "text": "<p><span style=\"font-size:12.0pt;\">Variable intrathoracic obstruction</span></p>"
      },
      {
        "id": 46101,
        "text": "<p><span style=\"font-size:12.0pt;\">Variable extra thoracic obstruction</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the pathology from the given flow-volume loop: (INICET MAY 2021)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-154508.png\" alt=\"\" width=\"300\" height=\"259\"></span></p>",
    "unique_key": "Q7690013",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066794,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) Fixed central airway obstruction</strong></span></p><p><br><span style=\"font-size:12pt;\">The flow-volume loop shows flattening of both the inspiratory and expiratory limbs, which is characteristic of a fixed central airway obstruction. This pattern suggests an obstruction that affects airflow both during inhalation and exhalation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Fixed distal airway obstruction</strong> would not typically affect both phases of the loop.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Variable intrathoracic obstruction</strong> affects the expiratory phase more.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D.</strong> <strong>Variable extrathoracic obstruction</strong> affects the inspiratory phase more.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Flattening of both inspiratory and expiratory limbs in a flow-volume loop indicates a fixed central airway obstruction.</span></p>",
    "correct_choice_id": 46099,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11780,
    "choices": [
      {
        "id": 47086,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 5 only</span></p>"
      },
      {
        "id": 47087,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4 and 5</span></p>"
      },
      {
        "id": 47088,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 5 only</span></p>"
      },
      {
        "id": 47089,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3, 4 and 5 only</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following are true regarding KF ring? (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Seen in all patients with neurological involvement</span></p><p><span style=\"font-size:12.0pt;\">2. Is pathognomonic for Wilson's disease</span></p><p><span style=\"font-size:12.0pt;\">3. Resolves with desferrioxamine</span></p><p><span style=\"font-size:12.0pt;\">4. Seen in all patients with hepatic involvement</span></p><p><span style=\"font-size:12.0pt;\">5. Seen in superior and inferior pole of Descemet's membrane</span></p>",
    "unique_key": "Q1452126",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066786,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;1 and 5 only.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 1</strong>: The Kayser-Fleischer ring is frequently seen in patients with neurological involvement due to Wilson\u2019s disease, but it may not be present in all cases.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 5</strong>: The Kayser-Fleischer ring is a copper deposit seen at the superior and inferior poles of the corneal Descemet's membrane.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 2</strong>: While the KF ring is highly suggestive of Wilson's disease, it is not solely pathognomonic because it can appear in other chronic cholestatic liver conditions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 3</strong>: Desferrioxamine is used for iron chelation and is not effective for copper removal in Wilson's disease. Treatment for copper overload involves agents like penicillamine or trientine.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Statement 4</strong>: Not all patients with hepatic involvement due to Wilson's disease will have visible KF rings, as their presence correlates more strongly with the duration and severity of copper accumulation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">KF can be seen in disorders causing chronic cholestasis. Seen in ~99% of patients with neuro wilson's, 44-60% with hepatic involvement.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Desferioxamine is chelating agent in iron toxicity.&nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Liver/Wilsons/Chap 344</strong></span></p>",
    "correct_choice_id": 47088,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11730,
    "choices": [
      {
        "id": 46886,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></span></span></span></p>"
      },
      {
        "id": 46887,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Chloroquine</span></span></span></span></p>"
      },
      {
        "id": 46888,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydroxychloroquine</span></span></span></span></p>"
      },
      {
        "id": 46889,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ketoconazole</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which of the following is used in the treatment of hypercalcemia due to Vitamin D toxicity?</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Aptos&quot;,sans-serif\"> (AIIMS NOV 2019)</span></span></p>",
    "unique_key": "Q3907651",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066837,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone is utilized in the treatment of hypercalcemia, particularly when induced by Vitamin D toxicity. This corticosteroid helps reduce calcium absorption from the intestine and increase calcium excretion, effectively lowering serum calcium levels.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Chloroquine:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Used primarily as an antimalarial and in autoimmune diseases, it does not play a role in managing hypercalcemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Hydroxychloroquine:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Similar to chloroquine, used for autoimmune disorders but not for hypercalcemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Ketoconazole:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">An antifungal medication that can reduce corticosteroid production but is not specifically used to treat hypercalcemia caused by Vitamin D toxicity</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Dexamethasone, Bisphosphonates, IV fluids, Loop diuretics, Calcitonin are used in the management of Hypercalcemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - (Harrison/Endocrinology/Hypercalcemia)</span></span></strong></span></span></p>",
    "correct_choice_id": 46886,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11610,
    "choices": [
      {
        "id": 46406,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4, 3</span></p>"
      },
      {
        "id": 46407,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 4, 3, 2</span></p>"
      },
      {
        "id": 46408,
        "text": "<p><span style=\"font-size:12.0pt;\">4, 3, 2, 1</span></p>"
      },
      {
        "id": 46409,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 4, 3, 1</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presents with fever and nuchal rigidity. The resident was instructed to perform a lumbar puncture on this patient. What is the correct order of managing this patient?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Place IV cannula and give fluids at 40 mL/h</span></li><li><span style=\"font-size:12.0pt;\">Start injection ceftriaxone</span></li><li><span style=\"font-size:12.0pt;\">Send CSF sample for biochemistry and microanalysis</span></li><li><span style=\"font-size:12.0pt;\">Perform guarded lumbar puncture</span></li></ol>",
    "unique_key": "Q7016773",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066845,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) 1, 4, 3, 2</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When managing a patient with fever and nuchal rigidity (suggesting possible meningitis), the correct order of steps is:</span></p><ol><li><span style=\"font-size:12.0pt;\">Place IV cannula and give fluids at 40 mL/h: Establishing IV access is the first priority to ensure hydration and create a route for medication administration.</span></li><li><span style=\"font-size:12.0pt;\">4. Perform guarded lumbar puncture: The lumbar puncture should be performed early to collect CSF samples before antimicrobial therapy alters the CSF findings.</span></li><li><span style=\"font-size:12.0pt;\">Send CSF sample for biochemistry and microanalysis: Once the CSF is collected, it must be promptly sent for laboratory analysis to identify potential pathogens and guide targeted therapy.</span></li><li><span style=\"font-size:12.0pt;\">Start injection ceftriaxone: After CSF collection, empiric antibiotic therapy with ceftriaxone should be initiated. This ensures that treatment doesn't interfere with CSF culture results while still providing timely antimicrobial coverage.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">This sequence prioritizes obtaining diagnostic samples before starting antimicrobial therapy, which is critical for accurate diagnosis while not unduly delaying treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In suspected meningitis, the ideal sequence is to secure samples for microbiological diagnosis before starting antibiotics, when clinically feasible. However, if there will be a significant delay in performing the lumbar puncture or if the patient is critically ill, antibiotics should not be delayed. The sequence emphasizes balancing the need for accurate diagnosis with timely intervention.</span></p>",
    "correct_choice_id": 46407,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": "",
    "video_explanation_heading": "",
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11697,
    "choices": [
      {
        "id": 46754,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PSVT </span></span></span></span></p>"
      },
      {
        "id": 46755,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular bigeminy</span></span></span></span></p>"
      },
      {
        "id": 46756,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">P pulmonale</span></span></span></span></p>"
      },
      {
        "id": 46757,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Re-entrant atrial fibrillation</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The given ECG depicts which of the following conditions:&nbsp; (AIIMS NOV 2018)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm112.jpg\" style=\"height:357px; width:700px\" /></p>",
    "unique_key": "Q5885480",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066805,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Ventricular bigeminy </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature ventricular complex (PVCs)- Have following features </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Broad QRS complex (&gt;120ms) with abnormal morphology</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Premature- i.e., occurs earlier than would be expected for the next sinus impulse</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Discordant ST segment and T wave changes.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Usually followed by a full compensatory pause</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">PVCs often occur in repeating pattern: bigeminy, trigeminy, quadrigeminy </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Couplet: 2 consecutive PVCs is known as couplet</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Triplet: 3 consecutive PVCs is known as triplet</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. PSVT (Paroxysmal Supraventricular Tachycardia):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This condition would show a fast, regular heart rate with narrow QRS complexes; not observed here.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. P pulmonale:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This involves peaked P waves seen in leads II, III, and aVF, typically due to right atrial enlargement; not evident in this ECG.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Re-entrant atrial fibrillation:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Would show an irregularly irregular rhythm without consistent P waves; this is not present in the ECG provided.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ventricular bigeminy is identified by the presence of alternating normal sinus beats and PVCs, each PVC typically followed by a compensatory pause, creating a repeating pattern of one normal beat followed by one abnormal beat.</span></span></span></span></p>",
    "correct_choice_id": 46755,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11577,
    "choices": [
      {
        "id": 46274,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium channel blocker </span></span></span></p>"
      },
      {
        "id": 46275,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Beta blocker </span></span></span></p>"
      },
      {
        "id": 46276,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Alpha blocker </span></span></span></p>"
      },
      {
        "id": 46277,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Diuretic</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">For the diagnosis of resistant hypertension, the patient should have uncontrolled hypertension despite taking three antihypertensive drugs. This should include at least one? (INICET MAY 2021)</span></span></p>",
    "unique_key": "Q3464222",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066813,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">D) Diuretic</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Resistant hypertension is defined as blood pressure that remains above the target levels despite the use of three antihypertensive agents of different classes, one of which should be a diuretic. This is because diuretics, typically thiazide diuretics, help to reduce blood volume and are effective in lowering blood pressure. Including a diuretic ensures optimal blood pressure control.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option A. Calcium channel blockers</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Calcium channel blockers are used but are not specifically required for the diagnosis of resistant hypertension.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option B. Beta blockers</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Beta blockers are also commonly used but not specifically required for the definition. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Option C. Alpha blockers</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">: Alpha blockers may be used as part of the treatment regimen but are not specifically required.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">The diagnostic criteria for resistant hypertension include having blood pressure above target despite taking three drugs, one of which must be a diuretic, OR having controlled blood pressure with four or more drugs. Typically, a thiazide diuretic is used in the setting of hypertension.</span></span></span></p>",
    "correct_choice_id": 46277,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11728,
    "choices": [
      {
        "id": 46878,
        "text": "<p><span style=\"font-size:12.0pt;\">Autoimmune adrenalitis</span></p>"
      },
      {
        "id": 46879,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypernephroma</span></p>"
      },
      {
        "id": 46880,
        "text": "<p><span style=\"font-size:12.0pt;\">Adrenocortical carcinoma</span></p>"
      },
      {
        "id": 46881,
        "text": "<p><span style=\"font-size:12.0pt;\">Medullary carcinoma thyroid</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Addison's disease is commonly associated with:&nbsp;(AIIMS NOV 2019)</span></p>",
    "unique_key": "Q1342696",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066835,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Autoimmune adrenalitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Addison's disease, primarily characterized by adrenal insufficiency, is most commonly associated with autoimmune adrenalitis. In this condition, the body's immune system attacks the adrenal cortex, leading to a decrease in the production of steroid hormones such as cortisol and aldosterone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Hypernephroma:&nbsp;</strong>Also known as renal cell carcinoma, hypernephroma is a type of kidney cancer and has no direct link to the adrenal function or Addison's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Adrenocortical carcinoma:&nbsp;</strong>This is a cancer of the adrenal cortex but typically leads to excessive hormone production, associated more with Cushing's syndrome rather than Addison's disease, where there is hormone deficiency.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Medullary carcinoma of the thyroid:&nbsp;</strong>This type of cancer is associated with the thyroid gland and is related to multiple endocrine neoplasia type 2 (MEN2) syndrome but not directly linked to Addison's disease.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:11.0pt;\">Addison's disease is most commonly caused by autoimmune adrenalitis, where the immune system mistakenly attacks the adrenal glands, leading to insufficient production of vital hormones.</span></p>",
    "correct_choice_id": 46878,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11738,
    "choices": [
      {
        "id": 46918,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></span></span></p>"
      },
      {
        "id": 46919,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methylthiouracil</span></span></span></span></p>"
      },
      {
        "id": 46920,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Levothyroxine</span></span></span></span></p>"
      },
      {
        "id": 46921,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hydrouracil</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A woman with Grave&#39;s disease was taking antithyroid medication throughout her pregnancy. The baby was born with aplasia cutis congenita. Which drug could have caused this condition? (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q2125201",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066844,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Carbimazole is a medication used to treat hyperthyroidism and is known to cause teratogenic effects if used during pregnancy. It can lead to a rare congenital condition called aplasia cutis congenita, where the baby is born with localized areas of missing skin. The use of carbimazole, especially during the first trimester of pregnancy, is linked with this embryopathy, which highlights the importance of careful medication selection in pregnant women with thyroid disorders.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Methylthiouracil:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although it is an antithyroid drug, it is less commonly used and not specifically associated with aplasia cutis congenita.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Levothyroxine:</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> This is a thyroid hormone replacement and is used to treat hypothyroidism, not associated with congenital defects.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Hydrouracil:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This option appears to be a distractor as no such common drug name exists that is relevant in this context.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MMZ, Carbimazole associated with embryonopathy in first trimester</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Graves in Pregnancy:</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&lt;16 weeks: PTU (MM teratogenic)</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">&gt;16 weeks: MMI (PTU hepatotoxicity)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactation: MMI (RAIA avoided 4-6 weeks after cessation of breastfeeding as RAI is concentrated in breast tissue)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21/Hyperthyroidism/Graves/Chap 384</span></span></strong></span></span></p>",
    "correct_choice_id": 46918,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11711,
    "choices": [
      {
        "id": 46810,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Repeat Inj. adenosine 6 mg</span></span></span></span></p>"
      },
      {
        "id": 46811,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized cardioversion</span></span></span></span></p>"
      },
      {
        "id": 46812,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Inj. amiodarone 300 mg</span></span></span></span></p>"
      },
      {
        "id": 46813,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DC cardioversion</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ECG of a patient who presented to the ER is as given below. The patient was already given a carotid massage and IV Adenosine but the BP is currently 60/30 mm Hg. What is the next best step of management? (AIIMS NOV 2019)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm97.jpg\" style=\"height:296px; width:700px\" /></span></span></span></span></p>",
    "unique_key": "Q1327024",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066819,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized Cardioversion</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Any hemodynamically unstable rhythm, requires synchronized cardioversion (Shock delivered in sync with R wave to prevent R-on T phenomenon). </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized Cardioversion&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is the correct choice for a hemodynamically unstable patient, as it is intended to restore normal heart rhythm without causing further cardiac risks. Synchronization ensures that the shock is delivered at a safe point in the QRS complex to prevent the induction of ventricular fibrillation.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Maximum of 30mg of adenosine can be tried if patient is <em>Hemodynamically Stable</em></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Amiodarone is used in the treatment of chronic arrhythmias and rarely for acute treatment of SVT</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12pt\"><span style=\"font-family:Calibri,sans-serif\"><strong>Option D.</strong>&nbsp;</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DC cardioversion&nbsp;</span></strong>technically refers to the same treatment as synchronized cardioversion in the context of unstable rhythms but the lack of specification about synchronization could imply a risk if not properly timed.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronised cardioversion avoid possibility of R on T phenomenon.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/screenshot-2024-09-11-112319.png\" style=\"height:445px; width:1000px\" /></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm118.jpg\" style=\"height:364px; width:700px\" /></span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In cases of hemodynamically unstable tachyarrhythmias where initial pharmacological interventions fail, synchronized cardioversion should be promptly employed to stabilize the patient. This technique is crucial for preventing progression to more severe complications such as cardiac arrest.</span></span></span></span></p>",
    "correct_choice_id": 46811,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ImageBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11714,
    "choices": [
      {
        "id": 46822,
        "text": "<p><span style=\"font-size:12.0pt;\">Metabolic alkalosis</span></p>"
      },
      {
        "id": 46823,
        "text": "<p><span style=\"font-size:12.0pt;\">Metabolic acidosis</span></p>"
      },
      {
        "id": 46824,
        "text": "<p><span style=\"font-size:12.0pt;\">Respiratory alkalosis</span></p>"
      },
      {
        "id": 46825,
        "text": "<p><span style=\"font-size:12.0pt;\">Respiratory acidosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient of hemophilia received multiple blood transfusions. Which of the following metabolic abnormalities can be seen in a patient? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q5985782",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066822,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Metabolic Alkalosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metabolic alkalosis in a patient who received multiple blood transfusions arises primarily from the metabolism of citrate, used as a preservative in stored blood products.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Massive transfusion (MT) is defined as the replacement by transfusion of <i>10 units of pRBCs </i>in 24 hours or more than <i>4 units of pRBCs</i> in one hour.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Excess citrate preservative gets converted to bicarbonate causing Metabolic alkalosis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Metabolic Acidosis:&nbsp;</strong>This condition would typically result from an accumulation of acids or loss of bicarbonate, which is not a direct consequence of blood transfusion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Respiratory Alkalosis:&nbsp;</strong>Would involve hyperventilation leading to decreased carbon dioxide levels, unrelated to transfusion effects.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Respiratory Acidosis:&nbsp;</strong>Involves hypoventilation increasing carbon dioxide levels, which is also unrelated to the effects of blood transfusions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Metabolic alkalosis is a potential complication of multiple or massive blood transfusions due to the metabolism of citrate preservative into bicarbonate, emphasizing the importance of monitoring electrolytes and acid-base balance during such procedures.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Additional Information</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/whatsapp-image-2024-09-11-at-101953-am.jpeg\" alt=\"\" width=\"1000\" height=\"1171\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/11/whatsapp-image-2024-09-11-at-101953-am-1.jpeg\" alt=\"\" width=\"1000\" height=\"694\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><u>Delayed complications:&nbsp;</u></strong>GVHD, PTP, Infections</span></p>",
    "correct_choice_id": 46822,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11703,
    "choices": [
      {
        "id": 46778,
        "text": "<p><span style=\"font-size:12.0pt;\">Total blood count with peripheral smear</span></p>"
      },
      {
        "id": 46779,
        "text": "<p><span style=\"font-size:12.0pt;\">CT thorax</span></p>"
      },
      {
        "id": 46780,
        "text": "<p><span style=\"font-size:12.0pt;\">Start cyclophosphamide</span></p>"
      },
      {
        "id": 46781,
        "text": "<p><span style=\"font-size:12.0pt;\">Urgent referral to RT</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 53-year-old patient was admitted complains of dyspnea. On examination he has puffy face, with engorged veins over the chest. SVC obstruction is suspected. Chest X-ray shows mediastinal enlargement. What is the next step? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q7216020",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066811,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) CT thorax</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Superior Vena Cava (SVC) obstruction, suggested by symptoms like dyspnea, facial puffiness, and engorged chest veins, along with a chest X-ray showing mediastinal enlargement, requires further detailed imaging to accurately assess the extent of the obstruction and the presence of any mediastinal masses. A CT scan of the thorax is the most appropriate next step as it provides detailed images of the chest's anatomy, helping to identify the cause of the SVC obstruction, which is crucial for planning appropriate management.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Total blood count with peripheral smear:&nbsp;</strong>While useful for general health assessments and diagnosing blood disorders, this does not directly address the structural issues seen in SVC obstruction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Start cyclophosphamide:&nbsp;</strong>Beginning chemotherapy like cyclophosphamide would only be appropriate after a specific diagnosis of a malignancy causing the SVC obstruction, confirmed via imaging and biopsy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Urgent referral to RT:&nbsp;</strong>Referral for radiation therapy (RT) may be necessary if a malignancy is confirmed, but it is premature without a detailed thoracic CT and biopsy if indicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CT thorax is critical for detailed evaluation in suspected SVC obstruction to confirm the diagnosis and guide further specific treatment, whether surgical, medical, or radiation therapy.</span></p>",
    "correct_choice_id": 46779,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11699,
    "choices": [
      {
        "id": 46762,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Sitagliptin </span></span></span></span></p>"
      },
      {
        "id": 46763,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pioglitazone </span></span></span></span></p>"
      },
      {
        "id": 46764,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Canagliflozin</span></span></span></span></p>"
      },
      {
        "id": 46765,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Liraglutide</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A morbidly obese diabetic woman is not responsive to metformin therapy. She has a history of pancreatitis and family history of bladder cancer. She does not want to take injections. Which of the following would be suitable to reduce her glucose levels? (AIIMS NOV 2018)</span></span></span></span></p>",
    "unique_key": "Q3460480",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066807,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Canagliflozin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Canagliflozin is a suitable oral medication for a diabetic patient not responding to metformin, especially when she has a history of pancreatitis and a family history of bladder cancer, and prefers to avoid injectable medications. Canagliflozin works by inhibiting the sodium-glucose co-transporter 2 (SGLT2), which helps the kidneys excrete glucose through urine, thus lowering blood glucose levels</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Sitagliptin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not ideal as it has been associated with a risk of acute pancreatitis, which poses a significant risk given her medical history.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Pioglitazone:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Should be avoided due to its potential link with bladder cancer, especially considering her family history.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Liraglutide:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although effective in managing diabetes, it is not suitable as it is an injectable medication and the patient prefers to avoid injections. Moreover, it also carries a risk of pancreatitis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In choosing diabetes medications for patients with specific health concerns, it&#39;s crucial to consider both the efficacy and the side-effect profile of the drug, as well as patient preferences for administration methods to ensure compliance and safety. Canagliflozin is an appropriate choice for this patient due to its oral administration and lower risk concerning her medical history.</span></span></span></span></p>",
    "correct_choice_id": 46764,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11701,
    "choices": [
      {
        "id": 46770,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypovolemic shock</span></span></span></span></p>"
      },
      {
        "id": 46771,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypocalcemia </span></span></span></span></p>"
      },
      {
        "id": 46772,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Seizures </span></span></span></span></p>"
      },
      {
        "id": 46773,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Allergic reaction</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A young donor came to the blood bank for the first time for platelet apheresis with platelet count of 1.9L. During the course he developed paraesthesia and circumoral numbness during donation. His vitals remained stable though. ECG showed tachycardia with ST-T changes. What is the reason for his symptoms? (AIIMS NOV 2018)</span></span></span></span></p>",
    "unique_key": "Q1817031",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066809,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Hypocalcemia</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hypocalcemia occurs due to citrate. It is due to calcium binding citrate anticoagulant used to keep blood from clotting in apheresis machine. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Treatment for this would be to slow down the flow of device and/or giving oral calcium supplements. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV calcium is only required in case of prolonged apheresis as in case of HPC collection.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Hypovolemic Shock:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This would be characterized by low blood pressure and signs of systemic shock, which are not described in this scenario.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Seizures:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Although severe hypocalcemia can lead to seizures, the description focuses on paraesthesia and numbness, common early signs of hypocalcemia, without any mention of convulsive activity.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Allergic Reaction:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The symptoms listed are not typical of allergic reactions, which might include hives, itching, or respiratory symptoms.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">During platelet apheresis, monitoring for symptoms of hypocalcemia is crucial due to the use of citrate. Symptoms such as tingling, numbness, and ECG changes warrant immediate evaluation and management, typically with calcium supplementation to counteract the effects of citrate.</span></span></span></span></p>",
    "correct_choice_id": 46771,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11706,
    "choices": [
      {
        "id": 46790,
        "text": "<p><span style=\"font-size:12.0pt;\">TB</span></p>"
      },
      {
        "id": 46791,
        "text": "<p><span style=\"font-size:12.0pt;\">Neisseria gonorrhea</span></p>"
      },
      {
        "id": 46792,
        "text": "<p><span style=\"font-size:12.0pt;\">Cryptococcus</span></p>"
      },
      {
        "id": 46793,
        "text": "<p><span style=\"font-size:12.0pt;\">Coxsackie</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient comes to ED with fever and headache. On examination, he has neck stiffness. CSF analysis was done and it shows the following findings. Most likely diagnosis is: (AIIMS NOV 2018)</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Opening pressure- increased</span></li><li><span style=\"font-size:12.0pt;\">Proteins- mildly increased</span></li><li><span style=\"font-size:12.0pt;\">Glucose \u2013 normal</span></li><li><span style=\"font-size:12.0pt;\">Lymphocytes- increased</span></li></ul>",
    "unique_key": "Q2624838",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066814,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Coxsackie</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The CSF findings indicative of increased lymphocytes, normal glucose levels, and mildly increased protein are characteristic of viral meningitis. Coxsackie virus, a common cause of viral meningitis, often presents with these CSF findings. The typical profile of viral meningitis includes normal glucose levels, which helps differentiate it from bacterial, fungal, and tuberculous meningitis where glucose levels are often decreased.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. TB:&nbsp;</strong>Tuberculous meningitis typically shows low glucose, high protein, and a mixed cellular response in the CSF, which does not match the patient's CSF profile.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Neisseria gonorrhea:&nbsp;</strong>Generally causes bacterial meningitis with a different CSF profile\u2014low glucose, high protein, and predominantly polymorphonuclear cells.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cryptococcus:&nbsp;</strong>Fungal meningitis also shows low glucose and is not consistent with the normal glucose levels observed in this patient.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/10/screenshot-2024-09-10-161535.png\" alt=\"\" width=\"1000\" height=\"550\"></p>",
    "correct_choice_id": 46793,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11715,
    "choices": [
      {
        "id": 46826,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal ABG</span></span></span></span></p>"
      },
      {
        "id": 46827,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Normal anion gap, metabolic acidosis</span></span></span></span></p>"
      },
      {
        "id": 46828,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap metabolic acidosis with metabolic alkalosis</span></span></span></span></p>"
      },
      {
        "id": 46829,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap metabolic alkalosis with normal metabolic acidosis</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient with renal failure develops vomiting in ICU. ABG analysis showed pH - 7.4, Na+ = 145 mEq/L, Cl- = 100 mEq/L, HC03- = 24mEq/L, PaC02 = 40 mmHg. What is the likely metabolic abnormality?</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Aptos&quot;,sans-serif\"> (AIIMS NOV 2019)</span></span></p>",
    "unique_key": "Q5332867",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066823,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap metabolic acidosis with metabolic alkalosis</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical history of renal failure should hint towards possibility of preexisting metabolic acidosis. Important in MCQs to always calculate AG even if ABG appears normal.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AG: 145-(100+24) = 21 (Normal ~12)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Excess unmeasured anion(H) combines with HCO3 thereby reducing the HCO3 proportionately. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hence Delta ratio i.e., &Delta;AG(AG-12) /&Delta;HCO3(24-HCO3) = &gt;2.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Value &gt;2 indicate coexisting Metabolic alkalosis</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Normal ABG:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The pH is indeed normal, but the underlying disturbances (as reflected by an increased anion gap) indicate that the system is not normal.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Normal anion gap, metabolic acidosis:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The anion gap is increased, ruling out normal anion gap acidosis.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. High anion gap metabolic alkalosis with normal metabolic acidosis:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This choice incorrectly identifies the nature of acid-base disturbances, confusing the interpretation and relationship between anion gap and bicarbonate levels.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In patients with renal failure and symptoms like vomiting, it&#39;s crucial to evaluate both the anion gap and changes in bicarbonate to identify complex acid-base disturbances such as the coexistence of high anion gap metabolic acidosis with metabolic alkalosis.</span></span></p>",
    "correct_choice_id": 46828,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11731,
    "choices": [
      {
        "id": 46890,
        "text": "<p><span style=\"font-size:12.0pt;\">Cardiac tamponade</span></p>"
      },
      {
        "id": 46891,
        "text": "<p><span style=\"font-size:12.0pt;\">Restrictive cardiomyopathy</span></p>"
      },
      {
        "id": 46892,
        "text": "<p><span style=\"font-size:12.0pt;\">Constrictive pericarditis</span></p>"
      },
      {
        "id": 46893,
        "text": "<p><span style=\"font-size:12.0pt;\">Tricuspid regurgitation</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Deep y descent in Jugular Venous Pressure (JVP) is seen in all of the following conditions except: (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q6159479",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066838,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Cardiac Tamponade</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Deep y descent in JVP (Jugular venous pressure) is a characteristic finding in several conditions that affect the filling of the right ventricle. These conditions include constrictive pericarditis, restrictive cardiomyopathy, and tricuspid regurgitation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cardiac tamponade, as it is associated with a blunted y descent in JVP rather than a deep y descent. In cardiac tamponade, the pericardial fluid accumulation restricts cardiac filling, leading to a decrease in the amplitude of the y descent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Restrictive cardiomyopathy:&nbsp;</strong>This condition can cause a deep y descent due to the stiff ventricular walls allowing rapid passive filling only during early diastole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Constrictive pericarditis:&nbsp;</strong>Similar to restrictive cardiomyopathy, constrictive pericarditis also shows a rapid early diastolic filling as the rigid pericardium constricts ventricular filling in late diastole, leading to a pronounced y descent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tricuspid regurgitation:&nbsp;</strong>In tricuspid regurgitation, right atrial emptying occurs without the normal resistance posed by a competent tricuspid valve, often resulting in a prominent y descent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In cardiac tamponade, the presence of fluid in the pericardial space restricts all phases of cardiac filling, leading to a blunted or absent y descent, differentiating it from conditions where a deep y descent is observed.</span></p>",
    "correct_choice_id": 46890,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11680,
    "choices": [
      {
        "id": 46686,
        "text": "<p><span style=\"font-size:12.0pt;\">Penicillin G</span></p>"
      },
      {
        "id": 46687,
        "text": "<p><span style=\"font-size:12.0pt;\">Ceftriaxone</span></p>"
      },
      {
        "id": 46688,
        "text": "<p><span style=\"font-size:12.0pt;\">Cefotetan</span></p>"
      },
      {
        "id": 46689,
        "text": "<p><span style=\"font-size:12.0pt;\">Cefoxitin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient came with complaints of high-grade fever &amp; altered sensorium. He was diagnosed to be suffering from meningococcal meningitis. Which of the following is the most appropriate empirical treatment? (AIIMS NOV 2017)</span></p>",
    "unique_key": "Q4464292",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066801,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B) Ceftriaxone</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ceftriaxone or cefotaxime is the drug of choice for empirical treatment of meningococcal meningitis. However, Penicillin G remains the antibiotic of choice for susceptible strains.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Empirical antimicrobial therapy is initiated in with patients with suspected bacterial meningitis before the results of CSF Gram stain and culture are known.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">S. pneumoniae and N. meningitidis are the most common etiologic organism of community acquired bacterial meningitis. Due to the emergence of penicillin resistant and cephalosporin resistant S. pneumoniae, empirical therapy of community acquired suspected bacterial meningitis should include a combination of \u2013</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Dexamethasone</span></li><li><span style=\"font-size:12.0pt;\">Third or fourth generation cephalosporin (E.g., ceftriaxone, cefotaxime or Cefepime)</span></li><li><span style=\"font-size:12.0pt;\">Vancomycin</span></li><li><span style=\"font-size:12.0pt;\">Acyclovir- HSV Encephalitis is the main differential</span></li><li><span style=\"font-size:12.0pt;\">Doxycycline \u2013during tick season</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Penicillin G:</strong> While effective against Neisseria meningitidis, it is not the first choice for empirical treatment due to broader resistance concerns and coverage needs in initial therapy settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cefotetan and D. Cefoxitin:</strong> These are second-generation cephalosporins, which are not typically used for the treatment of meningococcal meningitis due to insufficient CNS penetration and coverage compared to third-generation cephalosporins like ceftriaxone.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ceftriaxone is the preferred empirical therapy for meningococcal meningitis due to its effective CNS penetration, broad antibacterial coverage, and favorable dosing regimen. Immediate initiation of empirical therapy is crucial in suspected bacterial meningitis to prevent severe outcomes.</span></p>",
    "correct_choice_id": 46687,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11778,
    "choices": [
      {
        "id": 47078,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
      },
      {
        "id": 47079,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 4</span></p>"
      },
      {
        "id": 47080,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 4</span></p>"
      },
      {
        "id": 47081,
        "text": "<p><span style=\"font-size:12.0pt;\">2 and 5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A 23-year-old medical student developed epistaxis that resolved spontaneously. He has been afebrile for the last 24 hours and his platelet count is 14,000/\u00b5L. His BP is 110/70 mm of Hg and there is a 28% rise in hematocrit. What should be the management? (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. Give 4 units of platelets</span></p><p><span style=\"font-size:12.0pt;\">2. Give plenty of oral fluids</span></p><p><span style=\"font-size:12.0pt;\">3. Give IV fluids</span></p><p><span style=\"font-size:12.0pt;\">4. Keep under observation</span></p><p><span style=\"font-size:12.0pt;\">5. Discharge the patient</span></p>",
    "unique_key": "Q2541925",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066784,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;2, 3 and 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient likely has Dengue Hemorrhagic Fever, indicated by a significant rise in hematocrit, which suggests plasma leakage during the critical phase of the illness. The management strategy includes:</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\"><strong>Statement 2. Oral fluids </strong>to maintain hydration but must be balanced to avoid fluid overload.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Statement&nbsp;3. IV fluids </strong>are essential for the management of severe dengue to correct the plasma leakage and prevent shock.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Statement&nbsp;4. Observation </strong>is crucial to monitor for further complications such as dengue shock syndrome.</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. 1 and 2</strong>: Platelet transfusion is generally reserved for severe bleeding or very low platelet counts (typically &lt;10,000/\u00b5L without bleeding). This patient's platelet count, while low, does not alone justify transfusion without signs of active or severe bleeding.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. 1, 2 and 4</strong>: Includes unnecessary platelet transfusion without the clear presence of severe bleeding or extremely low platelet counts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. 2 and 5</strong>: Discharging the patient is inappropriate given the potential for rapid deterioration during the critical phase of dengue fever.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In dengue hemorrhagic fever, management focuses on careful fluid management and close observation during the critical phase to prevent or manage complications such as shock. Platelet transfusions are not routinely given based solely on low counts but are reserved for cases of significant clinical bleeding or extremely low platelet counts.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Note </strong>- There is no correlation between bleeding manifestation and platelet count.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Dengue Case management for Clinicians- CDC</strong></span></p>",
    "correct_choice_id": 47079,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11540,
    "choices": [
      {
        "id": 46126,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium oxalate</span></span></span></p>"
      },
      {
        "id": 46127,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Calcium phosphate</span></span></span></p>"
      },
      {
        "id": 46128,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Uric acid</span></span></span></p>"
      },
      {
        "id": 46129,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Cystine</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the urinary crystal shown below? (INICET MAY 2021)</span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/30/screenshot-2024-09-30-155713.png\" style=\"height:245px; width:300px\" /></span></span></p>",
    "unique_key": "Q3213675",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066797,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">A) Calcium oxalate</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium oxalate crystals are typically bipyramidal or envelope-shaped. These crystals are common in various conditions, including hyperoxaluria and ethylene glycol poisoning.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option B. Calcium phosphate: </strong>&nbsp;crystals form asymmetric rosettes. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Uric acid: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;crystals are rhomboid forming rosettes, </span><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">polychromatophilic in Polarized Microscope.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Cystine</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;crystals are hexagonal, and </span><span dir=\"ltr\" lang=\"EN\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">one of the hardest crystals. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Note - Monohydrate crystal &ndash; dumbbell shaped</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcium oxalate crystals are bipyramidal or envelope-shaped.</span></span></span></p>",
    "correct_choice_id": 46126,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11601,
    "choices": [
      {
        "id": 46370,
        "text": "<p><span style=\"font-size:12.0pt;\">Methemoglobinemia</span></p>"
      },
      {
        "id": 46371,
        "text": "<p><span style=\"font-size:12.0pt;\">Pulmonary arteriovenous fistula</span></p>"
      },
      {
        "id": 46372,
        "text": "<p><span style=\"font-size:12.0pt;\">High altitude</span></p>"
      },
      {
        "id": 46373,
        "text": "<p><span style=\"font-size:12.0pt;\">Hypothermia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a cause of central cyanosis?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
    "unique_key": "Q4343541",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066836,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Hypothermia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Central cyanosis occurs when there is a significant amount of deoxygenated hemoglobin in the blood, typically due to issues with oxygenation or hemoglobin abnormalities.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In contrast, <strong>hypothermia</strong> leads to <strong>peripheral cyanosis</strong>, not central cyanosis. In hypothermia, the blood flow is sluggish due to vasoconstriction, particularly in the extremities, which results in a bluish discoloration of the skin. However, the central organs typically remain oxygenated.</span></p><p><span style=\"font-size:11pt;\">&nbsp;</span></p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Central cyanosis can be caused by several factors:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Methemoglobinemia</strong>: This condition involves the presence of methemoglobin in the blood, which does not carry oxygen effectively, leading to central cyanosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Pulmonary Arteriovenous Fistula</strong>: This abnormal connection between an artery and a vein in the lungs allows blood to bypass the alveoli, leading to poorly oxygenated blood entering the systemic circulation, causing central cyanosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. High Altitude</strong>: At high altitudes, the reduced atmospheric pressure leads to lower oxygen availability, causing hypoxemia and central cyanosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hypothermia causes only peripheral cyanosis due to sluggish blood flow, not central cyanosis</span></p>",
    "correct_choice_id": 46373,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11582,
    "choices": [
      {
        "id": 46294,
        "text": "<p><span style=\"font-size:12.0pt;\">Kaposi's sarcoma</span></p>"
      },
      {
        "id": 46295,
        "text": "<p><span style=\"font-size:12.0pt;\">Melanoma</span></p>"
      },
      {
        "id": 46296,
        "text": "<p><span style=\"font-size:12.0pt;\">Invasive cervical carcinoma</span></p>"
      },
      {
        "id": 46297,
        "text": "<p><span style=\"font-size:12.0pt;\">Non-Hodgkin\u2019s lymphoma</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">AIDS-defining malignancies include all except: </span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
    "unique_key": "Q2042846",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066818,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) Melanoma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Melanoma</strong>, on the other hand, is a type of skin cancer primarily associated with UV exposure and is not considered an AIDS-defining malignancy. Although people with HIV/AIDS might have a higher risk of developing melanoma due to their immunocompromised state, it is not specifically used to define AIDS.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">AIDS-defining malignancies are specific types of cancer that are more likely to occur in people with AIDS. These cancers are used in the clinical definition of AIDS because they are directly associated with the immunosuppression caused by the HIV virus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Kaposi's sarcoma</strong>: This cancer is caused by Human Herpesvirus 8 (HHV-8) and is one of the most common AIDS-defining cancers. It manifests as vascular tumors that can appear on the skin and internal organs.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Invasive cervical carcinoma</strong>: This cancer is linked to the Human Papillomavirus (HPV) and is considered an AIDS-defining condition due to the increased risk in immunocompromised individuals.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Non-Hodgkin\u2019s lymphoma</strong>: Particularly the diffuse large B-cell lymphoma (DLBCL) and primary central nervous system (CNS) lymphoma, are common in AIDS patients due to the compromised immune system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Melanoma is not considered an AIDS-defining malignancy, unlike Kaposi's sarcoma, invasive cervical carcinoma, and non-Hodgkin\u2019s lymphoma.</span></p>",
    "correct_choice_id": 46295,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11527,
    "choices": [
      {
        "id": 46074,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 2</span></p>"
      },
      {
        "id": 46075,
        "text": "<p><span style=\"font-size:12.0pt;\">2 and 3</span></p>"
      },
      {
        "id": 46076,
        "text": "<p><span style=\"font-size:12.0pt;\">2 and 4</span></p>"
      },
      {
        "id": 46077,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2 and 3</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In a PHC, which of the following initial screening tests are used to diagnose diabetes? (INICET MAY 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">HbA1c &gt;6.5</span></li><li><span style=\"font-size:12.0pt;\">Fasting blood sugar &gt;126 mg/dL</span></li><li><span style=\"font-size:12.0pt;\">Random blood sugar &gt;200 mg/dL</span></li><li><span style=\"font-size:12.0pt;\">2-hour post glucose load blood sugar</span></li></ol>",
    "unique_key": "Q5563170",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066790,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) 2 and 3</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The initial screening tests for diagnosing diabetes in a primary health care setting generally include the following criteria:</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Fasting blood sugar &gt;126 mg/dL:</strong> A fasting blood glucose level of 126 mg/dL or higher on two separate occasions indicates diabetes. Fasting is defined as no caloric intake for at least 8 hours.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Random blood sugar &gt;200 mg/dL:</strong> A random blood glucose level of 200 mg/dL or higher, along with symptoms of diabetes, is sufficient for diagnosis. This test does not require fasting and can be taken at any time.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. HbA1c &gt;6.5%:</strong> While this test is beneficial for its ability to reflect average blood glucose levels over the past two to three months and does not require fasting, its higher cost and need for more sophisticated laboratory equipment make it less likely to be used at PHCs in India.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. 2-hour post glucose load blood sugar:</strong> Part of the Oral Glucose Tolerance Test (OGTT), this test is more comprehensive but requires more time and resources, which may not be feasible in all primary care settings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The initial screening tests for diagnosing diabetes in a primary health care (PHC) setting typically include fasting blood sugar &gt;126 mg/dL, and random blood sugar &gt;200 mg/dL. These tests are widely accepted and feasible in most PHC settings.</span></p>",
    "correct_choice_id": 46075,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11593,
    "choices": [
      {
        "id": 46338,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Blood glucose &lt;40 mg/dL</span></span></span></p>"
      },
      {
        "id": 46339,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Arterial pH &gt;7.2</span></span></span></p>"
      },
      {
        "id": 46340,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Serum creatinine - 5.2</span></span></span></p>"
      },
      {
        "id": 46341,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Unarousable coma</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A 40-year-old man presents with 15 days of fever and altered sensorium for 1 day. A rapid diagnostic test was done, and Plasmodium falciparum was diagnosed. Which of the following is not a complication?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q5491345",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066829,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. B) Arterial pH &gt;7.2</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">An <strong>arterial pH &gt;7.2</strong>, however, is not considered a complication of severe malaria. In fact, severe acidosis is defined by an arterial pH of less than 7.25, and it is a sign of severe malaria. Therefore, an arterial pH &gt;7.2 does not indicate severe malaria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Plasmodium falciparum malaria is a severe form of malaria that can lead to numerous complications. The World Health Organization (WHO) defines several criteria for severe malaria, many of which are seen in complicated cases of Plasmodium falciparum infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Blood glucose &lt;40 mg/dL</span></strong><span style=\"font-size:12.0pt\">: Severe hypoglycemia is a known complication of severe malaria, particularly in patients treated with quinine.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Serum creatinine - 5.2</span></strong><span style=\"font-size:12.0pt\">: This indicates severe renal impairment. Serum creatinine levels above 3 mg/dL or reduced urine output despite rehydration are markers of severe malaria.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Unarousable coma</span></strong><span style=\"font-size:12.0pt\">: Cerebral malaria, which includes unarousable coma or seizures, is one of the most severe complications of Plasmodium falciparum infection.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Diagnostic criteria for identifying complicated falciparum malaria, based on clinical and laboratory findings:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Arterial pH</span></strong><span style=\"font-size:12.0pt\">: An arterial pH of less than 7.25 is indicative of complicated falciparum malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bicarbonate Levels</span></strong><span style=\"font-size:12.0pt\">: A bicarbonate level of less than 15 is also a sign of complicated falciparum malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Base Deficit</span></strong><span style=\"font-size:12.0pt\">: A base deficit of more than 8 is another indicator of severe disease.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Hemoglobin</span></strong><span style=\"font-size:12.0pt\">: A hemoglobin level of less than 5, or the presence of hemoglobinuria, are significant markers of severity.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Venous Lactate</span></strong><span style=\"font-size:12.0pt\">: A venous lactate level of more than 5 further confirms the complexity and severity of the malaria infection.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Blood Glucose</span></strong><span style=\"font-size:12.0pt\">: A blood glucose level less than 40 mg/dL is a critical indicator of complicated falciparum malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Creatinine Levels</span></strong><span style=\"font-size:12.0pt\">: A creatinine level exceeding 3 mg/dL points to significant renal impairment associated with severe malaria.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Urine Output</span></strong><span style=\"font-size:12.0pt\">: A urine output of less than 400 mL per day, despite adequate rehydration with IV fluids, also signifies complicated falciparum malaria.</span></span></span></li>\r\n</ol>",
    "correct_choice_id": 46339,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11605,
    "choices": [
      {
        "id": 46386,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3, 4</span></p>"
      },
      {
        "id": 46387,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3</span></p>"
      },
      {
        "id": 46388,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2</span></p>"
      },
      {
        "id": 46389,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 4</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Chronic HBV infection would be consistent with which of the following serology? </span><span style=\"font-size:11pt;\">(</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">HBsAg</span></li><li><span style=\"font-size:12.0pt;\">Anti-HBsAg</span></li><li><span style=\"font-size:12.0pt;\">Anti-HBcAg</span></li><li><span style=\"font-size:12.0pt;\">HBV DNA</span></li></ol>",
    "unique_key": "Q4311905",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066840,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>A) 1, 3, 4</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Anti-HBs (Hepatitis B surface antibody)</strong>: This antibody appears after the infection has been cleared or following successful vaccination. It indicates immunity to HBV. In chronic HBV infection, this antibody is not present since the surface antigen is still active.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic hepatitis B virus (HBV) infection is defined by the persistence of the surface antigen (HBsAg) for more than six months. The presence of HBsAg indicates an active HBV infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Serological markers:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>1. HBsAg (Hepatitis B surface antigen)</strong>: This antigen indicates that the person is infectious. It is found in the blood during acute and chronic HBV infection. The presence of HBsAg for more than six months defines chronic HBV infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>3. Anti-HBc (Hepatitis B core antibody)</strong>: This antibody indicates previous or ongoing infection with HBV. In chronic infection, the IgG fraction of anti-HBc is usually present.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>4. HBV DNA</strong>: The presence of HBV DNA in the blood indicates active viral replication. It is usually detectable in chronic HBV infection, although the levels can vary.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Chronic HBV infection is characterized by the persistence of HBsAg, the presence of Anti-HBc, and usually detectable HBV DNA. Anti-HBs is not present in chronic HBV infection as it indicates immunity.</span></p>",
    "correct_choice_id": 46386,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11774,
    "choices": [
      {
        "id": 47062,
        "text": "<p><span style=\"font-size:12.0pt;\">ABCD</span></p>"
      },
      {
        "id": 47063,
        "text": "<p><span style=\"font-size:12.0pt;\">CABD</span></p>"
      },
      {
        "id": 47064,
        "text": "<p><span style=\"font-size:12.0pt;\">ABDC</span></p>"
      },
      {
        "id": 47065,
        "text": "<p><span style=\"font-size:12.0pt;\">ACBD</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Correct sequence after p wave: (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A- 'a' wave</span></p><p><span style=\"font-size:12.0pt;\">B- 1st heart sound</span></p><p><span style=\"font-size:12.0pt;\">C-Rapid filling of ventricles</span></p><p><span style=\"font-size:12.0pt;\">D- 't' wave</span></p>",
    "unique_key": "Q4905345",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066858,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;ABDC</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Following the P wave, which represents atrial depolarization leading to atrial contraction:</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>A- 'a' wave </strong>occurs as a result of atrial contraction, pushing blood into the ventricles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>B- 1st heart sound </strong>is produced by the closure of the mitral and tricuspid valves at the beginning of ventricular systole.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>D- 't' wave </strong>represents the repolarization of the ventricles, indicating the beginning of ventricular relaxation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>C- Rapid filling of ventricles </strong>follows as the ventricles relax and the atrioventricular valves open, allowing blood to flow from the higher pressure atria to the relaxed ventricles.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Electrical events precede mechanical events in cardiac homeostasis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">P wave\u2192 Atrial contraction (a wave).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">QRS\u2192 ventricular contraction (C wave)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">T wave\u2192 Ventricular relaxation (Early rapid filling (Y descent)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cardiology/Clinical/ chap 239</strong></span></p>",
    "correct_choice_id": 47064,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11751,
    "choices": [
      {
        "id": 46970,
        "text": "<p><span style=\"font-size:12.0pt;\">LDH</span></p>"
      },
      {
        "id": 46971,
        "text": "<p><span style=\"font-size:12.0pt;\">Troponin-T</span></p>"
      },
      {
        "id": 46972,
        "text": "<p><span style=\"font-size:12.0pt;\">CKMB</span></p>"
      },
      {
        "id": 46973,
        "text": "<p><span style=\"font-size:12.0pt;\">BNP</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with the complaints of chest pain. Which among the following is the best investigation to diagnose MI within 2-4 hours? (INICET NOV 2020)</span></p>",
    "unique_key": "Q7231088",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066848,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Troponin \u2013 T</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Troponin-T is the most sensitive and specific biomarker available for diagnosing myocardial infarction (MI) within the early hours of symptom onset. It begins to rise within 3-4 hours of myocardial damage, peaks at around 12-48 hours, and remains elevated for up to 7-10 days, making it highly useful for early diagnosis and detection of recent heart damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. LDH:</strong>&nbsp;it is a less specific enzyme that may be elevated in many types of tissue damage and is not ideal for early diagnosis of MI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. CKMB: it&nbsp;</strong>rises within 4-8 hours of myocardial injury, making it less useful than Troponin-T in the very early stages post-symptom onset.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. BNP:&nbsp;</strong>it is primarily used to assess heart failure and is not a primary marker for acute myocardial infarction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/13/screenshot-2024-09-13-110113.png\" alt=\"\" width=\"1000\" height=\"414\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rise by &gt;20%of troponin is used for diagnosis of Reinfarction</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Newer biomarkers: HFABP, miRNA1,21,33</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - (Cardiology/Biomarkers, MI)</strong></span></p>",
    "correct_choice_id": 46971,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11579,
    "choices": [
      {
        "id": 46282,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Sulfasalazine </span></span></span></p>"
      },
      {
        "id": 46283,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydroxychloroquine</span></span></span></p>"
      },
      {
        "id": 46284,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Methotrexate</span></span></span></p>"
      },
      {
        "id": 46285,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Azathioprine</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is NOT a first-line drug for the management of a patient with rheumatoid arthritis?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q6309258",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066816,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. D) Azathioprine</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The first-line drugs for the management of rheumatoid arthritis (RA) are typically Disease-Modifying Antirheumatic Drugs (DMARDs), which include sulfasalazine, hydroxychloroquine, and methotrexate. These drugs are considered core therapies and are often used together in what is known as &quot;triple therapy.&quot;</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sulfasalazine</span></strong><span style=\"font-size:12.0pt\">, <strong>hydroxychloroquine</strong>, and <strong>methotrexate</strong> are highly effective and commonly used in the treatment of RA. They form the backbone of conventional synthetic DMARDs (csDMARDs).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Azathioprine</span></strong><span style=\"font-size:12.0pt\">, on the other hand, is not a first-line drug for RA management. While it is used in some autoimmune conditions, it is not as effective for RA as the other mentioned drugs. Its efficacy is lower, and it is not commonly included in the standard RA treatment regimens.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option A.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Sulfasalazine</strong>:<strong> </strong>This drug is a part of the core therapies for RA and is commonly used as a first-line treatment. It is known for its effectiveness and is often used in combination with other DMARDs.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Hydroxychloroquine</span></strong><span style=\"font-size:12.0pt\">:<strong> </strong>Another key first-line drug for RA, hydroxychloroquine is widely used due to its efficacy and relatively favorable safety profile. It is often part of the triple therapy regimen.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Methotrexate</strong>: Methotrexate is considered the cornerstone of RA treatment and is usually the first drug prescribed. It is highly effective and forms the basis of most RA treatment protocols.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Azathioprine is not a first-line drug for the management of rheumatoid arthritis; the primary first-line drugs are sulfasalazine, hydroxychloroquine, and methotrexate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note - </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Sulfasalazine&nbsp;</span></strong><span style=\"font-size:12.0pt\">and <strong>Hydroxychloroquine</strong> are considered safe for use during pregnancy and are preferred in the management of RA among pregnant patients.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Azathioprine</span></strong><span style=\"font-size:12.0pt\"> is also somewhat safe during pregnancy, but it is not as effective for RA, so it is less preferred compared to Sulfasalazine and Hydroxychloroquine.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Methotrexate&nbsp;</span></strong><span style=\"font-size:12.0pt\">and <strong>Leflunomide</strong> are not safe for use during pregnancy and should be avoided due to potential risks to the developing fetus.</span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Additional Information:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Rheumatoid arthritis management: Range of biological disease-modifying antirheumatic drugs (bDMARDs) and targeted synthetic disease-modifying antirheumatic drugs (tsDMARDs). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-152511.png\" style=\"height:626px; width:1000px\" /></span></span></span></p>",
    "correct_choice_id": 46285,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11713,
    "choices": [
      {
        "id": 46818,
        "text": "<p><span style=\"font-size:12.0pt;\">Atypical pneumonia</span></p>"
      },
      {
        "id": 46819,
        "text": "<p><span style=\"font-size:12.0pt;\">Lung abscess</span></p>"
      },
      {
        "id": 46820,
        "text": "<p><span style=\"font-size:12.0pt;\">Hemorrhagic mediastinitis</span></p>"
      },
      {
        "id": 46821,
        "text": "<p><span style=\"font-size:12.0pt;\">Broncho pulmonary pneumonia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">What is the most common presentation of inhalational anthrax? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q7562893",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066821,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Hemorrhagic mediastinitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Inhalational of anthrax spores (&lt;5 microns) are phagocytosed by alveolar macrophages, carried to local mediastinal lymph nodes releasing toxins causing hemorrhagic mediastinitis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">It is category A bioterrorism agent along with plague, botulism</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment recommended with IV antibiotics (Ciprofloxacin+Clindamycin)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;Atypical pneumonia</strong> occurs in Chlamydia, Mycoplasma, Legionella pneumonia causing interstitial infiltrates</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Lung abscess</strong> is seen as complication of infection with anaerobes, complication of pneumonia, atypical organisms like burkholderia, Infective endocarditis with septic embolism</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;Bronchopneumonia occurs due to pneumococcus</strong>, H.influenza etc.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Hemorrhagic mediastinitis is the hallmark presentation of inhalational anthrax, indicating a severe systemic infection that requires immediate medical attention and aggressive antibiotic therapy. Awareness of this presentation is crucial, particularly in contexts involving potential exposure to anthrax spores, such as bioterrorism.</span></p>",
    "correct_choice_id": 46820,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11530,
    "choices": [
      {
        "id": 46086,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ART if CD4 &lt;200</span></span></span></p>"
      },
      {
        "id": 46087,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ART and then ATT after 2 weeks</span></span></span></p>"
      },
      {
        "id": 46088,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ATT and then ART after 2 weeks</span></span></span></p>"
      },
      {
        "id": 46089,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Start ATT and ART simultaneously</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A newly diagnosed HIV patient presented with fever, cough, and hemoptysis. His sputum sample showed acid-fast bacilli. What is the appropriate management for this patient? (INICET MAY 2021)</span></span></p>",
    "unique_key": "Q1357664",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066792,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. </span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) Start ATT and then ART after 2 weeks</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In HIV patients with tuberculosis (TB), it is crucial to start antitubercular therapy (ATT) first to reduce the mycobacterial load before initiating antiretroviral therapy (ART). This approach helps to avoid immune reconstitution inflammatory syndrome (IRIS), a life-threatening condition due to massive cytokine response triggered by a rapid increase in CD4 count., which can occur if ART is started too early. The general recommendation is to start ART by 2 weeks -2 months, after ATT initiation.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"><strong>Option A. Starting ART only if CD4 &lt;200:</strong> does not address the immediate need for TB treatment. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">. <strong>Starting ART before ATT</strong>: can lead to IRIS. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Starting both therapies simultaneously: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;increases the risk of IRIS.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">In HIV patients with TB, start ATT first and then initiate ART after 2 weeks-2 months duration.</span></span></span></p>",
    "correct_choice_id": 46088,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11696,
    "choices": [
      {
        "id": 46750,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">First degree of heart block</span></span></span></span></p>"
      },
      {
        "id": 46751,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">AR</span></span></span></span></p>"
      },
      {
        "id": 46752,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcified valve</span></span></span></span></p>"
      },
      {
        "id": 46753,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Mild MS</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Disappearance of loud S1 in mitral stenosis occurs in all except: (AIIMS NOV 2018)</span></span></span></span></p>",
    "unique_key": "Q5302971",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066804,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. D) Mild MS. </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loud S1 can be heard in mild MS also because loud S1 does not depend on severity of MS. </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Loud S1 is one of the auscultatory hallmarks of MS, however it can be attenuated in a variety of conditions: </span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Associated MR</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Long PR (first degree heart block)</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">CCF</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Severe AR- regurgitant jet may impinge on AML</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcified valve </span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. First degree heart block:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Here, the prolonged PR interval delays the closure of the mitral valve relative to ventricular contraction, often softening or eliminating the loud S1.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. AR (Aortic Regurgitation):&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The regurgitant flow in aortic regurgitation can prevent the mitral valve leaflets from closing tightly and sharply, thus softening the S1.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Calcified valve:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Calcification of the mitral valve leads to stiffening of the leaflets, which inhibits their rapid movement and thus reduces the intensity of S1.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In mitral stenosis, a loud S1 is typically present unless there is an associated condition that affects the mobility or timing of the mitral valve leaflet closure, such as calcification, regurgitation in other valves, or disturbances in electrical conduction that affect heart rhythm</span></span></span></span></p>",
    "correct_choice_id": 46753,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11721,
    "choices": [
      {
        "id": 46850,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-HBc Ab</span></p>"
      },
      {
        "id": 46851,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-HBe Ab</span></p>"
      },
      {
        "id": 46852,
        "text": "<p><span style=\"font-size:12.0pt;\">Anti-HBs Ab</span></p>"
      },
      {
        "id": 46853,
        "text": "<p><span style=\"font-size:12.0pt;\">HBsAg</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Patient affected with acute hepatitis B infection has currently come for follow up. Identify the serological marker marked in the image? (AIIMS NOV 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm121.jpg\" alt=\"\" width=\"500\" height=\"247\"></span></p>",
    "unique_key": "Q5712246",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066830,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Anti-HBc Ab</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anti Hbc Ab are produced against Hepatitis B infection. IgM is produced early and IgG later. Production of antibodies(A) is seen to correspond to gradual reduction of surface, envelop antigens.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm122.jpg\" alt=\"\" width=\"700\" height=\"317\"></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Person recovering from acute infection may have negative anti HbS levels with low HbsAg levels. This is called window period where there is a lag between development of antiHbS and HbsAg levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Anti-HBe Ab:&nbsp;</strong>These antibodies against the hepatitis B e antigen generally signify lower levels of viral replication. They are not represented at the marked point in the graph.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Anti-HBs Ab:&nbsp;</strong>These antibodies indicate recovery and immunity and typically appear after the disappearance of HBsAg, which occurs later than the timeframe shown for the marked serological marker.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. HBsAg:</strong>&nbsp;This is the earliest detectable viral antigen to appear in the blood following infection but declines as Anti-HBc Ab and later Anti-HBs appear.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective</strong>:</span></p><p>&nbsp;</p><p><span style=\"font-size:11.0pt;\">Anti-HBc antibodies are crucial in diagnosing hepatitis B infection, as they appear early after exposure and persist throughout the infection. They are typically seen during the \"window period\" when HBsAg starts to wane and before Anti-HBs becomes detectable, indicating the body's initial immune response to the infection.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/Hepatology/Viral hepatitis/ chap 339/</strong></span></p>",
    "correct_choice_id": 46850,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11588,
    "choices": [
      {
        "id": 46318,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Skepletions are present in Crohn&#39;s disease</span></span></span></p>"
      },
      {
        "id": 46319,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mucosal layers are involved in Crohn&#39;s disease and transmural involvement is seen in ulcerative colitis</span></span></span></p>"
      },
      {
        "id": 46320,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Inflammatory bowel disease has a strong genetic predisposition</span></span></span></p>"
      },
      {
        "id": 46321,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Crohn&#39;s disease is curable through surgical resection of the affected segment</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Mark the correct statement regarding inflammatory bowel disease (IBD):</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q5366775",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066824,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Skepletions are present in Crohn&#39;s disease</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Crohn&#39;s disease is a type of inflammatory bowel disease (IBD) that can affect any part of the gastrointestinal tract from the mouth to the anus. It is characterized by a patchy distribution of inflammation, which is often transmural (affecting the entire thickness of the bowel wall). Skeletions, also known as skip lesions, are a hallmark feature of Crohn&#39;s disease, where areas of inflamed tissue are interspersed with healthy tissue.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Mucosal layers are involved in Crohn&#39;s disease and transmural involvement is seen in ulcerative colitis</span></strong><span style=\"font-size:12.0pt\">: This statement is incorrect. Crohn&#39;s disease typically involves transmural inflammation, meaning it affects all layers of the bowel wall. On the other hand, ulcerative colitis is characterized by inflammation that is limited to the mucosal and submucosal layers of the colon and rectum.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Inflammatory bowel disease has a strong genetic predisposition</span></strong><span style=\"font-size:12.0pt\">: While there are genetic factors associated with IBD, such as mutations in the NOD2/CARD15 gene linked to Crohn&#39;s disease, the overall genetic predisposition is not considered strong. Environmental factors play a more significant role in the development of IBD.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Crohn&#39;s disease is curable through surgical resection of the affected segment</span></strong><span style=\"font-size:12.0pt\">: This statement is incorrect. Crohn&#39;s disease can affect any part of the gastrointestinal tract and is not curable by surgical resection. Surgery can help manage symptoms and complications but does not cure the disease. Ulcerative colitis, however, can be cured by surgical removal of the colon and rectum (total proctocolectomy).</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Skepletions (skip lesions) are a characteristic feature of Crohn&#39;s disease, distinguishing it from ulcerative colitis</span></span></span></p>",
    "correct_choice_id": 46318,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11755,
    "choices": [
      {
        "id": 46986,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal disorders</span></span></span></span></p>"
      },
      {
        "id": 46987,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Lactic acidosis</span></span></span></span></p>"
      },
      {
        "id": 46988,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetic ketoacidosis</span></span></span></span></p>"
      },
      {
        "id": 46989,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Salicylate poisoning</span></span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap acidosis with low bicarbonate levels is seen in all the following conditions except: (INICET NOV 2020)</span></span></p>",
    "unique_key": "Q5808368",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066851,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal Disorders</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High anion gap metabolic acidosis (HAGMA) is characterized by the accumulation of acids in the body, which are not accompanied by an increase in other measured anions, thus increasing the anion gap. This condition typically involves a decrease in bicarbonate as the body tries to buffer the excess hydrogen ions.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Lactic Acidosis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: This condition occurs when lactate levels increase in the bloodstream during tissue hypoxia, commonly seen in shock or severe dehydration, and results in HAGMA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Diabetic Ketoacidosis</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In DKA, the body produces high levels of blood acids called ketones, which lead to HAGMA.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Salicylate Poisoning</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: In salicylate toxicity, especially at higher doses, metabolic acidosis occurs due to uncoupling of oxidative phosphorylation, leading to HAGMA. Initially, salicylate stimulates the respiratory center causing a respiratory alkalosis, which can be followed by metabolic acidosis at higher doses.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Renal disorders typically cause non-anion gap metabolic acidosis (NAGMA) due to an inability to excrete acid or conserve bicarbonate, rather than high anion gap acidosis seen in conditions like lactic acidosis, diabetic ketoacidosis, and salicylate poisoning.</span></span></span></span></p>",
    "correct_choice_id": 46986,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11599,
    "choices": [
      {
        "id": 46362,
        "text": "<p><span style=\"font-size:12.0pt;\">Rewarming is the treatment of choice</span></p>"
      },
      {
        "id": 46363,
        "text": "<p><span style=\"font-size:12.0pt;\">Analgesics are contraindicated</span></p>"
      },
      {
        "id": 46364,
        "text": "<p><span style=\"font-size:12.0pt;\">Thrombolytics can be used</span></p>"
      },
      {
        "id": 46365,
        "text": "<p><span style=\"font-size:12.0pt;\">Amputation in severe cases</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A soldier operating in Siachen Glacier presents with numbness of his legs. Incorrect regarding the image given:</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-154108.png\" alt=\"\" width=\"300\" height=\"170\"></p>",
    "unique_key": "Q9708330",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066834,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B) Analgesics are contraindicated</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient described is likely suffering from frostbite, given the environmental conditions and symptoms of numbness and the visual sign of erythema on the toes. Frostbite occurs when skin and other tissues freeze due to exposure to extremely cold temperatures. The treatment and management of <strong>frostbite</strong> are critical to prevent long-term damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Analgesics are contraindicated:</strong> This is incorrect. Analgesics, especially opiate analgesics, are crucial during the rewarming process because it is extremely painful. Non-steroidal anti-inflammatory drugs (NSAIDs) should be avoided due to their potential to cause further vasoconstriction.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Rewarming is the treatment of choice:</strong> This is correct. The first line of treatment for frostbite is rapid rewarming in a water bath at 37-39\u00b0C (98.6-102.2\u00b0F). This helps to restore blood flow and minimize tissue damage.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Thrombolytics can be used:&nbsp;</strong>This is correct. In cases where frostbite is severe and the patient presents within 24 hours, thrombolytic therapy may be considered to restore blood flow and prevent tissue death. <strong>MR angiography</strong> can help assess the need for thrombolytics.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Amputation in severe cases:&nbsp;</strong>This is correct. In severe frostbite cases, where there is significant tissue necrosis, amputation may be necessary. This is typically decided based on a <strong>bone scan</strong> if the patient presents more than 24 hours after the injury.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For frostbite treatment, rewarming is essential, analgesics are indicated due to the pain associated with rewarming, thrombolytics can be used within 24 hours of injury, and amputation may be necessary in severe cases.</span></p>",
    "correct_choice_id": 46363,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11705,
    "choices": [
      {
        "id": 46786,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Thiamine </span></span></span></span></p>"
      },
      {
        "id": 46787,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyridoxine</span></span></span></span></p>"
      },
      {
        "id": 46788,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Folic acid </span></span></span></span></p>"
      },
      {
        "id": 46789,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Methylcobalamine</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A patient on anti-tubercular therapy develops tingling sensation in the limbs. Which of the following when substituted can result from in improvement of symptoms? (AIIMS NOV 2018)</span></span></span></span></p>",
    "unique_key": "Q1570779",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066817,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. B) Pyridoxine</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a case of peripheral neuropathy that occurs in ATT therapy due to isoniazid (INH)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">To treat this &ndash; Pyridoxine 10-25mg/day should be added to regimen.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">High risk patients for peripheral neuropathy include- malnutrition, chronic alcohol dependence, diabetes, HIV.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Thiamine:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">While important for nervous system function, thiamine is not typically depleted by INH therapy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Folic acid:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Not directly related to the neurological side effects of INH.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Methylcobalamin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Though important for nerve health, it is not the primary vitamin depleted by INH therapy.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pyridoxine (vitamin B6) supplementation is essential for patients receiving isoniazid as part of their anti-tubercular therapy to prevent or manage peripheral neuropathy symptoms.</span></span></span></span></p>",
    "correct_choice_id": 46787,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11568,
    "choices": [
      {
        "id": 46238,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3 and 4 correct</span></p>"
      },
      {
        "id": 46239,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, and 3 correct</span></p>"
      },
      {
        "id": 46240,
        "text": "<p><span style=\"font-size:12.0pt;\">2 and 3 correct</span></p>"
      },
      {
        "id": 46241,
        "text": "<p><span style=\"font-size:12.0pt;\">1 and 4 correct</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">In atrial fibrillation, choose the correct statements: (INICET MAY 2021)</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Novel oral anticoagulants (NOACs) used in the treatment of moderate to severe MS</span></li><li><span style=\"font-size:12.0pt;\">Anticoagulants should be given in patients with ischemic stroke due to atrial fibrillation</span></li><li><span style=\"font-size:12.0pt;\">NOACs are contraindicated in prosthetic valves</span></li><li><span style=\"font-size:12.0pt;\">All patients with atrial fibrillation who are not candidates for cardiac surgery can be started on beta-blockers</span></li></ol>",
    "unique_key": "Q3712308",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066808,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans.&nbsp;C) 2 and 3 correct</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Anticoagulants are indicated for ischemic stroke due to atrial fibrillation. NOACs are contraindicated in patients with prosthetic valves due to a lack of evidence on their efficacy and safety in this population.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">1. NOACs are not used for moderate to severe mitral stenosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">4. Beta-blockers or non-dihydropyridine calcium channel blockers are used for rate control but not universally applicable.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Anticoagulants are used for ischemic stroke in AF, and NOACs are contraindicated in prosthetic valves.</span></p>",
    "correct_choice_id": 46240,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11767,
    "choices": [
      {
        "id": 47034,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 &amp; 3; a, c, d</span></span></span></span></p>"
      },
      {
        "id": 47035,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 &amp; 4; b, c, e</span></span></span></span></p>"
      },
      {
        "id": 47036,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 &amp; 3; a, d</span></span></span></span></p>"
      },
      {
        "id": 47037,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2 &amp; 4; b, e</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A 13-year-old boy collapsed while playing football. ECG showed V5, V6 inversion and prominent inverted T-waves. 2D echocardiography showed the septal anterior motion of mitral valve leaflet. Which of the following features will be seen on clinical examination and which of the following are true regarding the management? (INICET NOV 2020)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Clinical findings</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">a. Pulsus bisferiens</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">b. Pulsus alternans</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">c. Ejection systolic murmur</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">d. Murmur increases on standing</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">e. Murmur decreases on standing</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Management</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1. Beta-blockers are given</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">2. Beta-blockers are contraindicated</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">3. ICD is indicated</span></span></span></span></p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">4. ICD is contraindicated</span></span></span></span></p>",
    "unique_key": "Q7117767",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066856,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">1 &amp; 3; a, c, d</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The echocardiography findings and symptoms are indicative of Hypertrophic Cardiomyopathy (HCM). In HCM, due to the thickening of the heart muscle, there is a dynamic obstruction to blood flow, often worsening with decreased preload, such as when standing.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulsus bisferiens&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(a) is commonly observed in conditions like HCM, where there are two distinct peaks in arterial pulse per cardiac cycle due to the dynamic obstruction.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ejection systolic murmur&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(c) is typical in HCM and is due to the obstruction of the left ventricular outflow tract.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Murmur increases on standing&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">(d) in HCM due to increased obstruction with reduced venous return.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Regarding management:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Beta-blockers (1)&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">are typically used in HCM to manage symptoms and reduce heart rate, thereby decreasing myocardial oxygen demand and the degree of obstruction.</span></span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ICD (Implantable Cardioverter-Defibrillator) (3)&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">is recommended in patients with HCM who are at high risk of sudden cardiac death.</span></span></span></span></li>\r\n</ul>\r\n\r\n<p style=\"margin-left:48px\"><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">ICD indicated&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">for all patients with &ge;1 risk factor for SCD or HCM-AF score &gt;6%</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MAVACAMTEN<em><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> </span></span></em>is recently approved drug which modulates b-myosin heavy chain (&darr;Bridging &amp; Inotropy) &amp; reduces the need for ablation by 80% in long term</span></span></span></span></p>\r\n\r\n<p style=\"margin-left:48px\">&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This&nbsp;is incorrect as it suggests that beta-blockers are contraindicated and includes &quot;murmur decreases on standing,&quot; which is not characteristic of HCM. Pulsus alternans (b), indicative of severe heart failure, is not typical in HCM without heart failure.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C.</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"> It&nbsp;misses the key management and diagnostic features by excluding the ejection systolic murmur, which is a significant finding in HCM.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. </span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This&nbsp;incorrectly includes beta-blockers as contraindicated and excludes the key symptom of an ejection systolic murmur. It also incorrectly suggests that ICD is contraindicated.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Key Points: </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">All murmurs decrease on standing except MVP and HCM.</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulsus bisferiens can be seen in HCM</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">HCM is characterized by myocyte disarray &amp; fibrosis causing increase risk of sudden cardiac death &amp; arrhythmias.</span></span></span></span></li>\r\n</ul>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Pulsus alternans is seen in LVF</span></span></span></span></li>\r\n</ul>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Reference - Harrison 21/Basics of CVS/Chap 239</span></span></strong></span></span></p>",
    "correct_choice_id": 47034,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11522,
    "choices": [
      {
        "id": 46054,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspergillus Niger - Voriconazole</span></span></span></p>"
      },
      {
        "id": 46055,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Aspergillus fumigatus - Micafungin</span></span></span></p>"
      },
      {
        "id": 46056,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Candida albicans - Amphotericin B</span></span></span></p>"
      },
      {
        "id": 46057,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Candida Krusei&ndash; Fluconazole</span></span></span></p>"
      }
    ],
    "text": "<p><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Identify the correct &#39;organism-drug to which it is intrinsically resistant&#39; pair: (INICET MAY 2021)</span></span></p>",
    "unique_key": "Q4740923",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066787,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D) Candida Krusei- Fluconazole</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Candida Krusei is known to be intrinsically resistant to fluconazole, which is a widely used antifungal agent. This resistance is due to the specific genetic and biochemical characteristics of C. Kruse, which include efflux pumps that actively expel the drug and alterations in the target enzyme of fluconazole, making it less effective.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Aspergillus Niger - Voriconazole:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Aspergillus Niger is not intrinsically resistant to voriconazole; in fact, voriconazole is one of the treatments of choice for Aspergillus infections.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Aspergillus fumigatus - Micafungin:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Aspergillus fumigatus is sensitive to echinocandins, including micafungin. It is not intrinsically resistant to this drug.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Candida albicans - Amphotericin B:</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> Candida albicans is sensitive to amphotericin B, which is a broad-spectrum antifungal with a wide range of activity against various fungal species.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Candida Krusei is intrinsically resistant to fluconazole.</span></span></span></p>",
    "correct_choice_id": 46057,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11538,
    "choices": [
      {
        "id": 46118,
        "text": "<p><span style=\"font-size:12.0pt;\">Test for ANCA</span></p>"
      },
      {
        "id": 46119,
        "text": "<p><span style=\"font-size:12.0pt;\">Biopsy to show granulomas</span></p>"
      },
      {
        "id": 46120,
        "text": "<p><span style=\"font-size:12.0pt;\">AFB staining of sputum</span></p>"
      },
      {
        "id": 46121,
        "text": "<p><span style=\"font-size:12.0pt;\">BAL</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient presented with sinusitis, ulcerative lesions on the nasopharynx, nodular lesions with cavitations of the lung, and renal failure. Which of the following is the most useful investigation in this patient? (INICET MAY 2021)</span></p>",
    "unique_key": "Q9993310",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066796,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;A) Test for ANCA</strong></span></p><p><br><span style=\"font-size:12pt;\">The clinical presentation of ENT involvement, lung nodules with cavitations, and renal failure suggests granulomatosis with polyangiitis (GPA). The ANCA (anti-neutrophil cytoplasmic antibodies) test is a useful diagnostic tool for GPA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br><span style=\"font-size:12pt;\"><strong>Option B. Biopsy to show granulomas</strong> is useful but more invasive.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. AFB staining of sputum</strong> is for TB, not GPA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. BAL (bronchoalveolar lavage):&nbsp;</strong> is not specific for diagnosing GPA.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">In suspected GPA, the ANCA test is the most useful initial investigation.</span></p>",
    "correct_choice_id": 46118,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11710,
    "choices": [
      {
        "id": 46806,
        "text": "<p><span style=\"font-size:12.0pt;\">Carotid sinus massage</span></p>"
      },
      {
        "id": 46807,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
      },
      {
        "id": 46808,
        "text": "<p><span style=\"font-size:12.0pt;\">Beta blocker</span></p>"
      },
      {
        "id": 46809,
        "text": "<p><span style=\"font-size:12.0pt;\">Defibrillator</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A Patient came with sudden onset palpitations. ECG showed narrow complex, regular tachycardia without P waves, and a rate of 160bpm. His BP is 96/68mmHg. What is the next step in management? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q4419626",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066825,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Carotid sinus massage.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Above ECG findings \u2013 narrow complex tachycardia without P waves with clinical finding of sudden onset palpitations suggest AV node reentrant tachycardia (AVNRT).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Next best step in management will be carotid sinus massage (or any other vagal maneuver).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Vagal maneuvers can terminate an approximate 10-20% of AVNRT.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Adenosine:&nbsp;</strong>Used if vagal maneuver fail, adenosine is the drug of choice because it can temporarily block AV node conduction and terminate reentrant tachycardias.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Beta blocker:&nbsp;</strong>Beta blockers are another pharmacological option if adenosine fails, used to slow the heart rate and control the symptoms.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Defibrillator:&nbsp;</strong>Not appropriate in this scenario as the patient is hemodynamically stable (SBP &gt;90 mmHg) and the tachycardia does not pose an immediate threat to life.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Carotid sinus massage is the first-line intervention for clinically stable patients presenting with AVNRT, potentially stopping the arrhythmia without the need for drug intervention.</span></p>",
    "correct_choice_id": 46806,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11596,
    "choices": [
      {
        "id": 46350,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amphotericin B</span></span></span></p>"
      },
      {
        "id": 46351,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Griseofulvin</span></span></span></p>"
      },
      {
        "id": 46352,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Dapsone</span></span></span></p>"
      },
      {
        "id": 46353,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Hydroxychloroquine</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A person presents to the hospital with fever and chills. Fever profile is ordered and is found to be negative for malaria and dengue. RK-39 test is found to be positive. What is the treatment of choice?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q1006239",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066832,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Ans.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>A) Amphotericin B</strong></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The RK-39 test is used to diagnose visceral leishmaniasis, which is also known as kala-azar. Visceral leishmaniasis is caused by the Leishmania parasite and is transmitted by the bite of infected sandflies. The test detects antibodies against the RK-39 antigen, which is a marker for this disease.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In India, the first-line treatment for visceral leishmaniasis is Amphotericin B. This drug is effective in treating the disease and is preferred due to its ability to clear the infection. While other treatments like sodium stibogluconate are available, Amphotericin B is the standard treatment due to its efficacy and safety profile in the Indian context.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option B.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Griseofulvin</strong>: This is an antifungal medication used to treat dermatophyte infections of the skin, hair, and nails. It is not effective against parasitic infections like leishmaniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option C.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Dapsone</strong>: This drug is primarily used to treat leprosy and certain types of dermatitis. It is not used for treating leishmaniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12pt\"><strong>Option D.</strong>&nbsp;</span><span style=\"font-size:12.0pt\"><strong>Hydroxychloroquine</strong>: This medication is used for the treatment of malaria, rheumatoid arthritis, and lupus erythematosus. It is not effective against leishmaniasis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective:</span></strong> </span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The RK-39 test is used to diagnose visceral leishmaniasis, and the treatment of choice for visceral leishmaniasis in India is Amphotericin B</span></span></span></p>",
    "correct_choice_id": 46350,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11712,
    "choices": [
      {
        "id": 46814,
        "text": "<p><span style=\"font-size:12.0pt;\">Facial nerve palsy</span></p>"
      },
      {
        "id": 46815,
        "text": "<p><span style=\"font-size:12.0pt;\">Masticator space abscess</span></p>"
      },
      {
        "id": 46816,
        "text": "<p><span style=\"font-size:12.0pt;\">Plexiform neurofibromatosis</span></p>"
      },
      {
        "id": 46817,
        "text": "<p><span style=\"font-size:12.0pt;\">Fibrous dysplasia</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Identify the clinical diagnosis: (AIIMS NOV 2019)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm119.jpg\" alt=\"\" width=\"365\" height=\"390\"></span></p>",
    "unique_key": "Q9095426",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066826,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C)&nbsp;Plexiform neurofibromatosis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Plexiform neurofibroma is seen in patients with NF1 commonly in the craniomaxillofacial region. Malignant transformation to MPNST (Malignant peripheral nerve sheath tumor) occurs in 3-16% patients and is the cause of mortality.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The mass typically appears as a \"bag of worms\" due to the involvement of multiple nerve branches.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Treatment is mainly surgical resection of the tumor</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>A</strong>.<strong> Facial nerve palsy:&nbsp;</strong>This condition typically presents with asymmetrical facial movement and weakness but does not cause mass-like growths.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>B</strong>.<strong> Masticator space abscess:&nbsp;</strong>Characterized by swelling and pain, usually due to an infection, which would not cause the extensive, benign proliferative growth seen in the image.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong></span><span style=\"font-size:11pt;\"> </span><span style=\"font-size:12.0pt;\"><strong>D. Fibrous dysplasia:&nbsp;</strong>While it can cause bone deformity and asymmetry, it does not manifest as a soft, extensive mass typically seen in neurofibromatosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Plexiform neurofibromatosis should be suspected in patients with extensive, soft, non-tender, and irregularly contoured masses along nerve pathways, particularly in those known to have or suspected of having NF1. Surgical resection can be considered for symptomatic relief or cosmetic reasons, though complete removal is often challenging due to the nature of the growth</span></p>",
    "correct_choice_id": 46816,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "Factual",
      "ImageBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11537,
    "choices": [
      {
        "id": 46114,
        "text": "<p><span style=\"font-size:12.0pt;\">Metastatic breast cancer</span></p>"
      },
      {
        "id": 46115,
        "text": "<p><span style=\"font-size:12.0pt;\">Multiple myeloma</span></p>"
      },
      {
        "id": 46116,
        "text": "<p><span style=\"font-size:12.0pt;\">Primary hyperparathyroidism</span></p>"
      },
      {
        "id": 46117,
        "text": "<p><span style=\"font-size:12.0pt;\">Milk Alkali Syndrome</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">An elderly woman presented with symptoms of confusion, thirst, and abdominal pain. On examination, she had pallor and thoracic spine tenderness. X-ray spine showed osteolytic lesions. Her lab investigations showed the following findings: Hb - 6.9g/dL, WBC 4000/cm3 with normal differential count, Serum calcium 13mg/dL, Creatinine 2.3mg/dL, Total protein 9g/dL, Albumin 2.4g/dL. What is the most likely diagnosis? (INICET MAY 2021)</span></p>",
    "unique_key": "Q8043353",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066795,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;B) Multiple myeloma</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">The patient's symptoms, combined with lab findings of anemia, hypercalcemia, elevated total protein, and low albumin, along with osteolytic lesions, are indicative of multiple myeloma. The <strong>CRAB criteria</strong> (hyperCalcemia, Renal failure, Anemia, and Bone lesions) support this diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span></p><p><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Metastatic breast cancer</strong> can present similarly but usually has a different primary site.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option C. Primary hyperparathyroidism</strong> causes hypercalcemia but not the full CRAB criteria.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Milk Alkali Syndrome</strong> causes hypercalcemia and renal impairment but not the protein abnormalities or osteolytic lesions.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Multiple myeloma is characterized by anemia, hypercalcemia, renal failure, and bone lesions.</span></p>",
    "correct_choice_id": 46115,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11587,
    "choices": [
      {
        "id": 46314,
        "text": "<p><span style=\"font-size:12.0pt;\">Contralateral hemiplegia</span></p>"
      },
      {
        "id": 46315,
        "text": "<p><span style=\"font-size:12.0pt;\">Fasciculation at the level of lesion</span></p>"
      },
      {
        "id": 46316,
        "text": "<p><span style=\"font-size:12.0pt;\">Upper motor neuron lesion and lower motor neuron lesion</span></p>"
      },
      {
        "id": 46317,
        "text": "<p><span style=\"font-size:12.0pt;\">Bladder involvement</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following does not help in the localization of lesions in the spinal cord?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p>",
    "unique_key": "Q8666133",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066827,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Contralateral hemiplegia</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When localizing lesions in the spinal cord, it is crucial to understand how different tracts and their associated functions are affected:</span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\"><strong>Corticospinal Tract</strong>: Damage to this tract results in ipsilateral hemiparesis (weakness) below the level of the lesion. This is because the corticospinal tract crosses over (decussates) at the medulla, above the spinal cord. Therefore, damage at the spinal cord level affects the same side of the body.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Posterior Column</strong>: Damage here leads to ipsilateral loss of light touch, vibration, proprioception, and pressure. Similar to the corticospinal tract, the posterior column pathways decussate above the spinal cord.</span></li><li><span style=\"font-size:12.0pt;\"><strong>Spinothalamic Tract</strong>: This tract, responsible for pain and temperature sensation, crosses at the level of the spinal cord itself. Damage to the spinothalamic tract results in contralateral loss of pain and temperature sensation.</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Given these pathways, <strong>contralateral hemiplegia</strong> <strong>suggests a lesion above the spinal cord</strong>, typically above the pyramidal decussation in the brainstem or higher. Therefore, it does not help in localizing lesions within the spinal cord itself.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Fasciculation at the level of lesion</strong>: Fasciculations are a sign of lower motor neuron involvement, which can occur at the level of the spinal cord lesion due to damage to the anterior horn cells. This helps in localizing the lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Upper motor neuron lesion and lower motor neuron lesion</strong>: The presence of both upper motor neuron (UMN) and lower motor neuron (LMN) signs can be indicative of a spinal cord lesion. UMN signs (such as spasticity and hyperreflexia) occur below the lesion, while LMN signs (such as fasciculations and muscle atrophy) occur at the level of the lesion.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Bladder involvement</strong>: Bladder and bowel dysfunction are common in transverse spinal cord lesions. This is due to the involvement of the autonomic pathways that control these functions, helping to localize the lesion within the spinal cord.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Contralateral hemiplegia indicates a lesion above the spinal cord, specifically above the level of pyramidal decussation.</span></p>",
    "correct_choice_id": 46314,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11700,
    "choices": [
      {
        "id": 46766,
        "text": "<p><span style=\"font-size:12.0pt;\">Supravalvular aortic stenosis</span></p>"
      },
      {
        "id": 46767,
        "text": "<p><span style=\"font-size:12.0pt;\">Coarctation of aorta</span></p>"
      },
      {
        "id": 46768,
        "text": "<p><span style=\"font-size:12.0pt;\">Takayasu arteritis</span></p>"
      },
      {
        "id": 46769,
        "text": "<p><span style=\"font-size:12.0pt;\">Aortic dissection</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient has right upper limb BP of &gt;180/95 mmHg and a left upper limb BP of 130/90 mmHg. He also has early diastolic murmur in right 2<sup>nd</sup> intercostal space. Which of the following is least likely to be associated with these findings? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q8697255",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066810,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Supravalvular aortic stenosis.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">An early diastolic murmur in the right 2<sup>nd</sup> intercostal space is suggestive of aortic regurgitation. Supravalvular aortic stenosis is least likely to be associated with the above findings.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">BP difference between arms is classical due to blood jet projected towards right brachiocephalic artery, but the murmur of AR is very rare.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>B. Coarctation of the Aorta:&nbsp;</strong>Can sometimes show differences in arm blood pressures, especially if the coarctation is proximal to the left subclavian artery. It is also associated with a bicuspid aortic valve, which can lead to AR.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option</strong>&nbsp;</span><span style=\"font-size:12.0pt;\"><strong>C. Takayasu Arteritis:&nbsp;</strong>Known for causing vascular inflammation leading to stenoses, which can result in differing blood pressures in the arms. About 25% of patients may also have AR.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option</strong>&nbsp;<strong>D. Aortic Dissection:&nbsp;</strong>Typically presents with differential blood pressure between arms and can rapidly lead to AR due to involvement of the aortic root.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">While differential arm blood pressure can suggest several cardiovascular anomalies, supravalvular aortic stenosis is least likely among the options given to be associated with these findings, especially concerning the presence of a diastolic murmur indicative of aortic regurgitation.</span></p>",
    "correct_choice_id": 46766,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "DiagnosisBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11787,
    "choices": [
      {
        "id": 47114,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Decreased GFR </span></span></span></span></p>"
      },
      {
        "id": 47115,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Increased creatinine </span></span></span></span></p>"
      },
      {
        "id": 47116,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia </span></span></span></span></p>"
      },
      {
        "id": 47117,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Proteinuria</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Which among the following is the most severe manifestation of CKD? (INICET NOV 2020)</span></span></span></span></p>",
    "unique_key": "Q2124079",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066793,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C) Hyperkalemia&nbsp; </span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia, characterized by elevated potassium levels in the blood, is particularly dangerous in CKD due to its direct impact on cardiac function. High potassium levels can disrupt normal heart rhythms, potentially leading to life-threatening cardiac arrhythmias.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Decreased GFR</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: While it indicates the progression of CKD and reduced kidney function, it does not pose immediate life-threatening risks like hyperkalemia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Increased creatinine</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Indicates kidney dysfunction but is a marker rather than a direct cause of severe clinical consequences.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Proteinuria</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">: Signifies kidney damage; however, it is more of a prognostic indicator rather than an acute life-threatening condition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Hyperkalemia in CKD patients is a critical condition that requires immediate medical attention due to its potential to cause fatal cardiac disturbances. Always prioritize the management of hyperkalemia in CKD patients to prevent cardiac complications.</span></span></span></span></p>",
    "correct_choice_id": 47116,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11757,
    "choices": [
      {
        "id": 46994,
        "text": "<p><span style=\"font-size:12.0pt;\">PCl</span></p>"
      },
      {
        "id": 46995,
        "text": "<p><span style=\"font-size:12.0pt;\">Prophylaxis for arrhythmia</span></p>"
      },
      {
        "id": 46996,
        "text": "<p><span style=\"font-size:12.0pt;\">Thrombolysis with alteplase</span></p>"
      },
      {
        "id": 46997,
        "text": "<p><span style=\"font-size:12.0pt;\">Aspirin with heparin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient comes to the hospital within 3 hours of the onset of chest pain. ECG revealed ST depression in anterior chest leads and T wave inversion. She could be best managed by? (INICET NOV 2020)</span></p>",
    "unique_key": "Q6312545",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066852,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D. Aspirin with heparin</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The description of diffuse symmetric TWI without ST elevations is consistent with NSTEMI which is characterized by subtotal platelet-rich thrombosis + distal phasic embolization. NSTEMI treated with DAPT+LMWH followed by CAG for risk stratification</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A.&nbsp;</strong>PCI is treatment of choice for STEMI.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>Arrhythmia prophylaxis is not the definitive best management strategy</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>Thrombolysis/Fibrinolytics have no role in the management of NSTEMI</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-105103.png\" alt=\"\" width=\"1000\" height=\"848\"></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Cardiology/ACS/Chap 277</strong></span></p>",
    "correct_choice_id": 46997,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11569,
    "choices": [
      {
        "id": 46242,
        "text": "<p><span style=\"font-size:12.0pt;\">Area postrema syndrome</span></p>"
      },
      {
        "id": 46243,
        "text": "<p><span style=\"font-size:12.0pt;\">Acute Myelitis</span></p>"
      },
      {
        "id": 46244,
        "text": "<p><span style=\"font-size:12.0pt;\">Focal epilepsy</span></p>"
      },
      {
        "id": 46245,
        "text": "<p><span style=\"font-size:12.0pt;\">Optic neuritis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is not a major diagnostic criterion of neuromyelitis Optica? (INICET MAY 2021)</span></p>",
    "unique_key": "Q2781351",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066812,
    "difficulty_level": "difficult",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;C) Focal epilepsy</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Neuromyelitis optica (NMO) spectrum disorder, also known as Devic's disease, is an autoimmune condition characterized by severe, recurrent episodes of optic neuritis and myelitis. The diagnostic criteria for NMO spectrum disorders include specific clinical syndromes. &nbsp;</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Focal epilepsy</strong> is not a diagnostic criterion for NMO. While seizures can occur in NMOSD due to brain lesions, focal epilepsy itself is not a major diagnostic feature.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option A. Area postrema syndrome&nbsp;</strong>&nbsp;is major criteria. This is characterized by intractable nausea, vomiting, or hiccups, which is due to lesions in the area postrema of the brainstem.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option B. Acute myelitis</strong> is major criteria. Inflammation of the spinal cord, usually longitudinally extensive (spanning three or more vertebral segments).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Option D. Optic neuritis</strong> is major criteria. This involves inflammation of the optic nerve, leading to vision loss or impairment, often affecting both eyes.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Diagnostic Criteria for Neuromyelitis Optica Spectrum Disorder (NMOSD)</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Most Common Core Clinical criteria:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Longitudinal extensive transverse myelitis (acute myelitis)</span></li><li><span style=\"font-size:12.0pt;\">Optic neuritis, often bilateral</span></li><li><span style=\"font-size:12.0pt;\">Area postrema syndrome</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Less Common Clinical Criteria:</strong></span></p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Acute brainstem syndrome</span></li><li><span style=\"font-size:12.0pt;\">Acute diencephalic syndrome, which can manifest as symptomatic narcolepsy</span></li><li><span style=\"font-size:12.0pt;\">Symptomatic cerebral syndrome (symptomatic cerebral lesions)</span></li></ol><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Some patients with NMOSD may have anti-NMO IgG antibody positivity, also known as anti-aquaporin 4 antibody (AQP4-IgG).</span></p>",
    "correct_choice_id": 46244,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11760,
    "choices": [
      {
        "id": 47006,
        "text": "<p><span style=\"font-size:12.0pt;\">Congestive heart failure</span></p>"
      },
      {
        "id": 47007,
        "text": "<p><span style=\"font-size:12.0pt;\">Budd Chiari syndrome</span></p>"
      },
      {
        "id": 47008,
        "text": "<p><span style=\"font-size:12.0pt;\">Cirrhosis</span></p>"
      },
      {
        "id": 47009,
        "text": "<p><span style=\"font-size:12.0pt;\">Tuberculosis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">50 yr old gentleman presented with progressive abdominal distension with shifting dullness on examination and dilated veins on lateral chest wall. Ascitic fluid analysis given below. What is the likely diagnosis? (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-105207.png\" alt=\"\" width=\"1000\" height=\"462\"></span></p>",
    "unique_key": "Q2895738",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066853,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. B)&nbsp;Budd-Chiari syndrome</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Presence of lateral dilated veins with high SAAG, low protein suggests Late Budd-Chiari syndrome.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">SAAG=Serum albumin- Ascitic Albumin = 2g/dl</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Interpretation</strong></span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">\u22651.1: Portal Hypertension (Transudate)</span></li><li><span style=\"font-size:12.0pt;\">&lt;1.1: Exudate</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Ascitic fluid protein helps identify sinusoidal vs non-sinusoidal causes</span></p><p>&nbsp;</p><ul><li><span style=\"font-size:12.0pt;\">Ascitic fluid protein &gt;2.5 = non-sinusoidal&nbsp;&nbsp;</span></li></ul><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Congestive Heart Failure</strong>: Typically presents with high SAAG and high protein content in the ascitic fluid.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Cirrhosis</strong>: While cirrhosis can also present with high SAAG, it usually shows low protein content in the ascitic fluid, which aligns with this case, but the presence of dilated veins specific to Budd-Chiari provides a more accurate diagnosis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Tuberculosis</strong>: Tuberculous peritonitis typically presents with a low SAAG and high protein content, which is inconsistent with the findings in this case.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/12/screenshot-2024-09-12-105251.png\" alt=\"\" width=\"1000\" height=\"350\"></strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Hepatology/ascites</strong></span></p>",
    "correct_choice_id": 47007,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "DiagnosisBased",
      "ImageBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11679,
    "choices": [
      {
        "id": 46682,
        "text": "<p><span style=\"font-size:12.0pt;\">Lignocaine</span></p>"
      },
      {
        "id": 46683,
        "text": "<p><span style=\"font-size:12.0pt;\">Digoxin</span></p>"
      },
      {
        "id": 46684,
        "text": "<p><span style=\"font-size:12.0pt;\">DC Cardioversion</span></p>"
      },
      {
        "id": 46685,
        "text": "<p><span style=\"font-size:12.0pt;\">Lidocaine</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 50-year-old man is brought to emergency following an episode of syncope during his morning walk. His blood pressure is 80/60 mmHg. He has a history of myocardial infarction 5yrs back. His ECG is given below. Which is the most appropriate treatment for patient? (</span>AIIMS Nov 2017)</p><p style=\"text-align:justify;\">&nbsp;</p><p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/26/nm111.jpg\" alt=\"\" width=\"700\" height=\"328\"></span></p>",
    "unique_key": "Q9249489",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066800,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) DC Cardioversion.</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The given ECG shows wide QRS complex with no P wave suggesting the diagnosis of ventricular tachycardia. Clinical features of exercise intolerance and the presence of ischemic heart disease also support the diagnosis of VT. Since patient hemodynamically unstable, next best step is DC Cardioversion. For stable patients, amiodarone is given intravenously.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Lignocaine and D. Lidocaine:</strong> These are antiarrhythmic drugs used for ventricular arrhythmias but are less appropriate in acute, hemodynamically unstable VT where immediate cardioversion is preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Digoxin: </strong>Typically used for heart rate control in atrial fibrillation and not suitable for acute VT, especially in the context of hemodynamic instability.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In a patient presenting with ventricular tachycardia and signs of hemodynamic instability, DC Cardioversion is the recommended treatment to quickly restore normal heart rhythm. Pharmacological treatments like amiodarone may be considered post-cardioversion for rhythm stabilization in stable patients.</span></p>",
    "correct_choice_id": 46684,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ImageBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11546,
    "choices": [
      {
        "id": 46150,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 3 and 4</span></p>"
      },
      {
        "id": 46151,
        "text": "<p><span style=\"font-size:12.0pt;\">2, 3 and 4</span></p>"
      },
      {
        "id": 46152,
        "text": "<p><span style=\"font-size:12.0pt;\">3, 4 and 5</span></p>"
      },
      {
        "id": 46153,
        "text": "<p><span style=\"font-size:12.0pt;\">1, 2, 3, 4 and 5</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">During the discharge of a COVID patient who was treated with steroids and remdesivir, which of the following will you inform him about? (INICET MAY 2021)</span></p><p>&nbsp;</p><p>&nbsp;</p><ol><li><span style=\"font-size:12.0pt;\">Repeat RT-PCR after 7 days of discharge</span></li><li><span style=\"font-size:12.0pt;\">Watch for the persistence of Anosmia</span></li><li><span style=\"font-size:12.0pt;\">Watch for Headache and nasal discharge</span></li><li><span style=\"font-size:12.0pt;\">Monitor glucose levels</span></li><li><span style=\"font-size:12.0pt;\">Watch for Sinusitis-like symptoms</span></li></ol>",
    "unique_key": "Q8133458",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066798,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans.&nbsp;C) 3, 4 and 5</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Discharging a COVID-19 patient involves providing instructions for monitoring ongoing or potential symptoms and managing side effects of treatments such as steroids and remdesivir.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>3. Watch for headache and nasal discharge:</strong> These symptoms can be part of the post-COVID syndrome or could indicate secondary infections like sinusitis, especially after treatment that might suppress the immune system.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>4. Monitor glucose levels:</strong> Steroids, often used in the treatment of severe COVID-19, can elevate blood glucose levels. It\u2019s crucial for patients, especially those with pre-existing diabetes or those who experienced high glucose levels during treatment, to monitor their levels after discharge.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>5. Watch for sinusitis-like symptoms:</strong> As with headache and nasal discharge, symptoms like those of sinusitis might suggest secondary infections, which are important to monitor given the use of immunomodulating treatments like steroids.</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Other Options:</strong></span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>1. Repeat RT-PCR after 7 days of discharge:&nbsp;</strong>Repeat RT-PCR after 7 days of discharge is not required as per updated guidelines<strong>.</strong> Repeat RT-PCR at 7 days of discharge was&nbsp;initially suggested, but later on removed from the guideline.&nbsp;</span><br>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>2. Watch for the persistence of Anosmia:&nbsp;</strong>Watch for the persistence of Anosmia is a common symptom (Anosmia can persist for weeks together) but, not matching with the options (actual answer should be 2,3,4, and 5).</span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12pt;\">Patients recovering from COVID-19 should monitor for symptoms of headache and nasal discharge, glucose levels due to steroid use, and sinusitis-like symptoms which could indicate secondary infections like mucormycosis.</span></p>",
    "correct_choice_id": 46152,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "INICET",
      "InvestigationBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11604,
    "choices": [
      {
        "id": 46382,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Complete transection of spinal cord</span></span></span></p>"
      },
      {
        "id": 46383,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ipsilateral loss of vibration &amp; touch</span></span></span></p>"
      },
      {
        "id": 46384,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Contralateral loss of pain &amp; temperature</span></span></span></p>"
      },
      {
        "id": 46385,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Ipsilateral loss of proprioception</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Which of the following is not a feature of Brown-S&eacute;quard syndrome?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q6018597",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066839,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. A) Complete transection of spinal cord</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A <strong>complete transection of the spinal cord</strong> is not a feature of Brown-S&eacute;quard syndrome. A complete transection would result in loss of all motor and sensory functions below the level of the injury on both sides of the body, which is different from the hemisection seen in Brown-S&eacute;quard syndrome.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brown-S&eacute;quard syndrome results from a hemisection or partial lesion of the spinal cord, typically affecting one half. This syndrome is characterized by a distinct pattern of neurological deficits due to the disruption of different spinal cord tracts.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Ipsilateral loss of vibration &amp; touch</span></strong><span style=\"font-size:12.0pt\">: This occurs because the posterior columns (dorsal columns) are affected, leading to loss of proprioception, vibration, and fine touch on the same side as the lesion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option C. Contralateral loss of pain &amp; temperature</span></strong><span style=\"font-size:12.0pt\">: This results from the damage to the spinothalamic tract, which crosses to the opposite side of the spinal cord. Therefore, pain and temperature sensations are lost on the side opposite to the lesion.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Ipsilateral loss of proprioception</span></strong><span style=\"font-size:12.0pt\">: Like the loss of vibration and touch, proprioception is also affected ipsilaterally due to involvement of the posterior columns.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Brown-S&eacute;quard syndrome is characterized by hemisection of the spinal cord, leading to ipsilateral loss of vibration, touch, and proprioception, and contralateral loss of pain and temperature. Complete transection of the spinal cord is not a feature of this syndrome</span></span></span></p>",
    "correct_choice_id": 46382,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "DiagnosisBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11722,
    "choices": [
      {
        "id": 46854,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV calcium</span></span></span></span></p>"
      },
      {
        "id": 46855,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">DC Shock</span></span></span></span></p>"
      },
      {
        "id": 46856,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV MgS04</span></span></span></span></p>"
      },
      {
        "id": 46857,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Synchronized cardioversion</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ECG of a pregnant lady having pre-eclampsia is shown below. Her vitals are stable. What is the best step in the management of the condition?</span></span><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Aptos&quot;,sans-serif\"> (AIIMS NOV 2019)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\"><img alt=\"\" src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm123.jpg\" style=\"height:337px; width:600px\" /></span></span></span></span></p>",
    "unique_key": "Q7947414",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066831,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. C)&nbsp;</span></span></strong><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">IV MgSO4</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">The ECG displays characteristics consistent with Torsades de Pointes (Tdp), which is identified by its distinctive polymorphic ventricular tachycardia and a prolonged QT interval. In the setting of pre-eclampsia, magnesium sulfate (MgSO4) is not only used for seizure prophylaxis but also effectively treats Torsades de Pointes by stabilizing the cardiac membrane and correcting magnesium deficiency, a common trigger for this arrhythmia.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. IV calcium:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Used for treating hyperkalemia or hypocalcemia-induced cardiac toxicity, not directly effective for Torsades de Pointes.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. DC Shock:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Indicated for hemodynamically unstable patients with Tdp or other life-threatening arrhythmias, which does not apply here as the patient&#39;s vitals are stable.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Synchronized cardioversion:&nbsp;</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Typically used for managing ventricular tachycardia with a pulse or superventricular tachycardia, but not the first-line for Torsades de Pointes in a stable patient.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective</span></span></strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">:</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span dir=\"ltr\" lang=\"EN\" style=\"font-size:11.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">In a stable pregnant patient displaying Torsades de Pointes, especially in the context of pre-eclampsia, IV magnesium sulfate is the recommended treatment. It helps in both controlling the arrhythmia and providing prophylaxis against eclamptic seizures.</span></span></p>",
    "correct_choice_id": 46856,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ImageBased",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11723,
    "choices": [
      {
        "id": 46858,
        "text": "<p><span style=\"font-size:12.0pt;\">Cytomegalovirus</span></p>"
      },
      {
        "id": 46859,
        "text": "<p><span style=\"font-size:12.0pt;\">Epstein-Barr virus</span></p>"
      },
      {
        "id": 46860,
        "text": "<p><span style=\"font-size:12.0pt;\">Varicella zoster virus</span></p>"
      },
      {
        "id": 46861,
        "text": "<p><span style=\"font-size:12.0pt;\">Herpes simplex virus</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Which of the following is the most common cause of infection post-solid organ transplantation in an Indian setting? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q8852149",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066833,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Cytomegalovirus</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">CMV is most common infection occurring after transplant. Risk depends on induction agent and seropositivity status. Minimal risk for D-/R-(Donor, recipient negative). Highest risk of reactivation in D-/R+ and patients who received anti-lymphocyte therapy. Prophylaxis is given pre-emptively if periodic CMV-DNA PCR are &gt;500 copies/ml with Valgan/ Foscarnet/Cidofovir. Letermovir has no hepato/nephrotoxicity (Safest)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">D-/R- patients should receive leucodepleted blood products to minimise transmission of CMV</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;</strong>EBV infection occurs in 1-2% of post-transplant patients and responds well to acyclovir prophylaxis</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;</strong>VZV reactivation can occur at any point post-transplant</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D.&nbsp;</strong>HSV occurs within 1-month post-transplant in the absence of acyclovir prophylaxis&nbsp;Nephrology/infectious diseases/post-transplant</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Cytomegalovirus (CMV) is the most prevalent and clinically significant viral infection in the post-solid organ transplant setting in India, necessitating targeted prophylaxis and monitoring protocols to mitigate its risks.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Critical Care Nephrology /Chapter 95</strong></span></p>",
    "correct_choice_id": 46858,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11704,
    "choices": [
      {
        "id": 46782,
        "text": "<p><span style=\"font-size:12.0pt;\">Cirrhosis</span></p>"
      },
      {
        "id": 46783,
        "text": "<p><span style=\"font-size:12.0pt;\">Liver failure</span></p>"
      },
      {
        "id": 46784,
        "text": "<p><span style=\"font-size:12.0pt;\">Metastasis to liver</span></p>"
      },
      {
        "id": 46785,
        "text": "<p><span style=\"font-size:12.0pt;\">TB peritonitis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A patient with ascites is found to have SAAG \u2265 1.1. All of the following causes except: (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q3798675",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066788,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) TB peritonitis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The Serum-Ascites Albumin Gradient (SAAG) is calculated to differentiate between ascites caused by portal hypertension (high SAAG \u2265 1.1) and ascites caused by other reasons (low SAAG &lt; 1.1). A SAAG value \u2265 1.1 indicates that the ascites is likely due to issues related to portal hypertension, such as cirrhosis, liver failure, or metastasis to the liver, which can also cause portal hypertension. Tuberculosis peritonitis, however, typically presents with a SAAG lower than 1.1 because it is not associated with portal hypertension but rather with peritoneal inflammation and capillary leak.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Cirrhosis:&nbsp;</strong>Directly associated with portal hypertension and commonly results in a SAAG \u2265 1.1.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Liver failure:&nbsp;</strong>Often leads to portal hypertension, causing a high SAAG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Metastasis to liver:&nbsp;</strong>Can impede hepatic blood flow and increase portal pressure, also leading to a high SAAG.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/04/27/nm114.jpg\" alt=\"\" width=\"700\" height=\"443\"></strong></span></p>",
    "correct_choice_id": 46785,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "DiagnosisBased",
      "InvestigationBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11571,
    "choices": [
      {
        "id": 46250,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2</span></span></span></p>"
      },
      {
        "id": 46251,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3</span></span></span></p>"
      },
      {
        "id": 46252,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 4</span></span></span></p>"
      },
      {
        "id": 46253,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">1, 2, 3, 4</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Acid-base imbalance is suspected in a patient. Which of the following would you use to determine it? (INICET MAY 2021)</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ol>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Arterial pH</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Venous pH</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Venous pO2</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Venous pCO2</span></span></span></li>\r\n</ol>",
    "unique_key": "Q5780678",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066850,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">C) 1, 2, 4</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arterial pH is the gold standard for acid-base analysis as it directly measures the hydrogen ion concentration in arterial blood, providing a precise assessment of the patient&#39;s acid-base status. Venous pH and venous pCO2 can also provide reliable information about the patient&rsquo;s acid-base status and are often used in clinical settings where arterial blood gas (ABG) analysis is not feasible.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">1. Arterial pH and 2. Venous pH</span></strong><span style=\"font-size:12.0pt\">:&nbsp; </span><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Arterial pH: This is the most accurate method for assessing acid-base balance. </span><span style=\"font-size:12.0pt\">Arterial pH varies by only 0.03 to 0.05 from venous pH. To estimate arterial pH from venous pH, add 0.03 to 0.05.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">4.</span></strong> <strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Venous pCO2: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">To estimate arterial pCO2 (PaCO2) from venous pCO2, subtract 5 from venous pCO2.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Venous pH and venous pCO2 can be used in some situations to predict arterial values.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">3. Venous pO2</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\"> is not useful for determining acid-base imbalance.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Arterial pH, venous pH, and venous pCO2 are used to determine acid-base imbalances.</span></span></span></p>",
    "correct_choice_id": 46252,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "CriteriaBased",
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11784,
    "choices": [
      {
        "id": 47102,
        "text": "<p><span style=\"font-size:12.0pt;\">A &amp; B only</span></p>"
      },
      {
        "id": 47103,
        "text": "<p><span style=\"font-size:12.0pt;\">A, B, C &amp; D only</span></p>"
      },
      {
        "id": 47104,
        "text": "<p><span style=\"font-size:12.0pt;\">A, B, &amp; C</span></p>"
      },
      {
        "id": 47105,
        "text": "<p><span style=\"font-size:12.0pt;\">B, C, &amp; D</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">You are posted as an intern in casualty. An elderly 60-year-old man is brought to you with complaints of chest pain. He has tested positive for COVID. Which of the following features will prompt you to get this patient admitted to dedicated COVID health centre? (INICET NOV 2020)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">A. Respiratory rate of 25/min</span></p><p><span style=\"font-size:12.0pt;\">B. SpO2 93%</span></p><p><span style=\"font-size:12.0pt;\">C. Multiple comorbidities</span></p><p><span style=\"font-size:12.0pt;\">D. Age</span></p>",
    "unique_key": "Q1462614",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066791,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt;\"><strong>Ans. B) A, B, C &amp; D only</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>A &amp; B Respiratory rate of 25/min </strong>and&nbsp;<strong>SpO2 93% </strong>: Both of these values are indicative of potential respiratory compromise, which is concerning in a COVID-19 patient. These values suggest the need for closer monitoring and possible oxygen supplementation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>C. Multiple comorbidities</strong>: Patients with multiple comorbidities are at a higher risk of severe disease and complications from COVID-19, warranting admission for close monitoring and treatment.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>D. Age</strong>: Age is a known risk factor for severity and complications in COVID-19. Older patients, like the 60-year-old man in the scenario, generally have poorer outcomes and may benefit from hospital care.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">When evaluating a COVID-19 patient for hospital admission, consider clinical signs of respiratory distress, overall oxygen saturation, presence of comorbidities, and age due to their significant impacts on disease severity and outcome.</span></p>",
    "correct_choice_id": 47103,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "CriteriaBased",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11762,
    "choices": [
      {
        "id": 47014,
        "text": "<p><span style=\"font-size:12.0pt;\">SLE</span></p>"
      },
      {
        "id": 47015,
        "text": "<p><span style=\"font-size:12.0pt;\">Ulcerative colitis</span></p>"
      },
      {
        "id": 47016,
        "text": "<p><span style=\"font-size:12.0pt;\">Behcet's disease</span></p>"
      },
      {
        "id": 47017,
        "text": "<p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">Iritis is seen in all except: (INICET NOV 2020</span></p>",
    "unique_key": "Q2172577",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066854,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. D) Rheumatoid Arthritis</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Iritis, or inflammation of the iris, is not commonly associated with Rheumatoid Arthritis (RA). Instead, RA is more commonly linked to other ocular conditions such as episcleritis and scleritis, which affect different parts of the eye.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. SLE</strong>: Systemic Lupus Erythematosus can involve various parts of the eye, including the development of uveitis, which includes iritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ulcerative Colitis</strong>: This inflammatory bowel disease is known to have extraintestinal manifestations including uveitis, which encompasses iritis.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Behcet's Disease:</strong>&nbsp;This is a multisystem inflammatory disorder that commonly affects the eyes, including the iris, making iritis a typical manifestation.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Rheumatoid arthritis is typically associated with <strong>scleral and episcleral inflammation</strong> rather than iritis, distinguishing it from other autoimmune conditions like SLE, Ulcerative Colitis, and Behcet's Disease that can present with iritis as a part of their systemic manifestations.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison/Rheumatology/Rheumatoid arthritis</strong></span></p>",
    "correct_choice_id": 47017,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11709,
    "choices": [
      {
        "id": 46802,
        "text": "<p><span style=\"font-size:12.0pt;\">Doxycycline</span></p>"
      },
      {
        "id": 46803,
        "text": "<p><span style=\"font-size:12.0pt;\">Ciprofloxacin</span></p>"
      },
      {
        "id": 46804,
        "text": "<p><span style=\"font-size:12.0pt;\">Chloramphenicol</span></p>"
      },
      {
        "id": 46805,
        "text": "<p><span style=\"font-size:12.0pt;\">Azithromycin</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">The drug of choice for treating scrub typhus? (AIIMS NOV 2018)</span></p>",
    "unique_key": "Q6418774",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066802,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A) Doxycycline</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Scrub typhus, caused by <i>Orientia tsutsugamushi</i>, is effectively treated with Doxycycline, which is considered the first-line treatment. Doxycycline is administered at a dosage of 100 mg twice daily for 7 to 14 days. It disrupts protein synthesis in the bacterium, which is crucial for its effectiveness against this intracellular pathogen.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">In pregnancy/children- Azithromycin/ chloramphenicol preferred.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. Ciprofloxacin:&nbsp;</strong>While it is a broad-spectrum antibiotic, it is not the preferred treatment for scrub typhus.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C. Chloramphenicol:&nbsp;</strong>This is an alternative treatment option but is generally reserved for cases where doxycycline or azithromycin cannot be used.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Azithromycin:&nbsp;</strong>This is a suitable alternative, especially in special populations such as pregnant women and children, where doxycycline is contraindicated.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">Doxycycline is the first-choice medication for treating scrub typhus in adults and non-pregnant women, offering effective relief and eradication of the pathogen when taken for the recommended duration.</span></p>",
    "correct_choice_id": 46802,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11573,
    "choices": [
      {
        "id": 46258,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Parkinson&#39;s disease</span></span></span></p>"
      },
      {
        "id": 46259,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Wilson&#39;s disease</span></span></span></p>"
      },
      {
        "id": 46260,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Neurodegeneration with Brain Iron Accumulation</span></span></span></p>"
      },
      {
        "id": 46261,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Huntington&#39;s chorea</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-size:12.0pt\">Which of the following does not show both hyperkinetic and hypokinetic movements? (INICET MAY 2021)</span></span></span></p>",
    "unique_key": "Q6512765",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066855,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans.&nbsp;</span></strong><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">D) Huntington&#39;s chorea</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Huntington&#39;s chorea is characterized by hyperkinetic movements such as chorea but does not typically present with hypokinetic movements.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Huntington&#39;s chorea presents with a classic triad of abnormal movements (chorea), dementia, and psychiatric manifestations. It also has a strong family history due to its inherited nature.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></strong></span></span><br />\r\n&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option A. Parkinson&#39;s disease</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">: &nbsp;Parkinson&#39;s disease shows both tremors (hyperkinetic) and bradykinesia (hypokinetic). </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Wilson&#39;s disease: </span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">&nbsp;Wilson&#39;s disease can present with a combination of movement disorders. </span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Neurodegeneration</span></strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\"> <strong>with Brain Iron Accumulation</strong>: &nbsp;Neurodegeneration with Brain Iron Accumulation also shows mixed movement disorders.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><strong><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></strong></span></span></p>\r\n\r\n<p><br />\r\n<span style=\"font-size:12pt\"><span style=\"font-family:&quot;Times New Roman&quot;,serif\"><span dir=\"ltr\" lang=\"EN-US\" style=\"font-family:&quot;Calibri&quot;,sans-serif\">Huntington&#39;s chorea primarily presents with hyperkinetic movements and not hypokinetic movements.</span></span></span></p>",
    "correct_choice_id": 46261,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "Factual",
      "INICET"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11720,
    "choices": [
      {
        "id": 46846,
        "text": "<p><span style=\"font-size:12.0pt;\">Mineralocorticoids</span></p>"
      },
      {
        "id": 46847,
        "text": "<p><span style=\"font-size:12.0pt;\">Glucocorticoids</span></p>"
      },
      {
        "id": 46848,
        "text": "<p><span style=\"font-size:12.0pt;\">Thyroid hormones</span></p>"
      },
      {
        "id": 46849,
        "text": "<p><span style=\"font-size:12.0pt;\">Estradiol</span></p>"
      }
    ],
    "text": "<p style=\"text-align:justify;\"><span style=\"font-size:12.0pt;\">A 56-year-old woman presented with a gradually diminishing visual field. She was found to have a pituitary mass and underwent trans-sphenoidal hypophysectomy. Now she has low levels of ACTH, TSH, FSH, and LH. Which of the following hormone supplements is not needed in the patient postoperatively? (AIIMS NOV 2019)</span></p>",
    "unique_key": "Q5670260",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066828,
    "difficulty_level": "intermediate",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. A)&nbsp;Mineralocorticoids</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">After a trans-sphenoidal hypophysectomy, the pituitary gland's ability to produce several hormones including ACTH, TSH, FSH, and LH can be impaired. The lack of ACTH typically necessitates glucocorticoid replacement, but not mineralocorticoid supplementation. This is because the regulation of mineralocorticoids (primarily aldosterone) is mainly via the renin-angiotensin-aldosterone system (RAAS), which operates independently of the pituitary gland. Aldosterone secretion is primarily controlled by plasma potassium levels and the RAAS, not ACTH, although ACTH can have a stimulatory effect.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B.&nbsp;Glucocorticoids: </strong>Low dose steroid supplementation is required as they are ACTH dependent.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option C.&nbsp;Thyroid hormones:</strong> Necessary due to diminished TSH, which is essential for thyroid hormone synthesis and secretion. LT4 supplementation targeting T4 levels is required.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Estradiol: </strong>While gonadotropin supplementation post-pituitary surgery can be complex, replacement might be necessary due to the absence of FSH and LH, affecting estrogen levels.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p><br><span style=\"font-size:12.0pt;\">Post-hypophysectomy, patients often require supplementation of several hormones, including glucocorticoids and thyroid hormones, due to impaired pituitary function. However, mineralocorticoid supplementation is typically not needed as aldosterone secretion is primarily regulated by the RAAS system, independent of pituitary control.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Reference - Harrison 21E/ Chapter 379/</strong></span></p>",
    "correct_choice_id": 46846,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "ClinicalVignette",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11612,
    "choices": [
      {
        "id": 46414,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Amoxicillin-clavulanic acid + Azithromycin</span></span></span></p>"
      },
      {
        "id": 46415,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Co-trimoxazole + steroids</span></span></span></p>"
      },
      {
        "id": 46416,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Co-trimoxazole only</span></span></span></p>"
      },
      {
        "id": 46417,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Antitubercular treatment</span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">A patient, who is a known case of HIV with a CD4 count of 200 cells/cu.mm, presents with 5 days of cough and high-grade fever without chills and rigors. There is no history of diarrhea, vomiting, or nuchal rigidity. Chest x-ray is normal. What treatment will you give?</span> (<span style=\"font-size:12.0pt\">INICET MAY 2022)</span></span></span></p>",
    "unique_key": "Q3330194",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066847,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Ans. C) Co-trimoxazole only</span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">In a patient with HIV and a CD4 count of 200 cells/cu.mm presenting with symptoms such as cough and fever, but with a normal chest x-ray, <strong>Pneumocystis jirovecii pneumonia (PCP)</strong> is a likely diagnosis. PCP is a common opportunistic infection in HIV patients, especially when the CD4 count is below 200 cells/cu.mm.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">The treatment of choice for PCP is co-trimoxazole (trimethoprim-sulfamethoxazole). It is essential to start treatment empirically in suspected cases of PCP because delayed treatment can lead to significant morbidity and mortality. The dose of co-trimoxazole is typically higher for treating PCP than for prophylaxis.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Steroids are indicated in severe cases of PCP to reduce inflammation, specifically if the patient has hypoxemia (PaO2 &lt; 70 mmHg) or an alveolar-arterial (A-a) gradient &gt; 35 mmHg. In this scenario, there is no data indicating severe disease, so co-trimoxazole alone is appropriate.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Other Options: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option A. Amoxicillin-clavulanic acid + Azithromycin:&nbsp;</span></strong><span style=\"font-size:12.0pt\">This combination is used for bacterial pneumonia, not PCP. Given the normal chest x-ray and the patient&#39;s clinical presentation, bacterial pneumonia is less likely.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option B. Co-trimoxazole + steroids:&nbsp;</span></strong><span style=\"font-size:12.0pt\">Steroids are added in severe cases of PCP. However, there is no evidence in this case of severe hypoxemia or an increased A-a gradient to justify the use of steroids along with co-trimoxazole.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Option D. Antitubercular treatment:&nbsp;</span></strong><span style=\"font-size:12.0pt\">There is no indication from the clinical presentation or the normal chest x-ray that the patient has tuberculosis. Antitubercular treatment is therefore not appropriate in this scenario.</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Educational Objective: </span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">For HIV patients with a CD4 count below 200 cells/cu.mm and presenting with cough and fever but a normal chest x-ray, co-trimoxazole is the first-line treatment for suspected PCP</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><span style=\"font-size:12.0pt\">Note - For a patient with a CD4 count of 200 and lower respiratory tract symptoms:</span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<ul>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">PCP Pneumonia</span></strong><span style=\"font-size:12.0pt\">: Suspect if the chest X-ray is normal or negative.</span></span></span></li>\r\n\t<li><span style=\"font-size:11pt\"><span style=\"font-family:Calibri,sans-serif\"><strong><span style=\"font-size:12.0pt\">Bacterial Pneumonia</span></strong><span style=\"font-size:12.0pt\">: Suspect if the chest X-ray shows consolidation or examination reveals bronchial breath sounds.</span></span></span></li>\r\n</ul>",
    "correct_choice_id": 46416,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11602,
    "choices": [
      {
        "id": 46374,
        "text": "<p><span style=\"font-size:12.0pt;\">Amiodarone</span></p>"
      },
      {
        "id": 46375,
        "text": "<p><span style=\"font-size:12.0pt;\">DC Cardioversion</span></p>"
      },
      {
        "id": 46376,
        "text": "<p><span style=\"font-size:12.0pt;\">Adenosine</span></p>"
      },
      {
        "id": 46377,
        "text": "<p><span style=\"font-size:12.0pt;\">Verapamil</span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:12.0pt;\">A female patient presents to the hospital with palpitations. Her vitals are stable, and the ECG shows the following. Which of the following is used as first-line management to treat the condition?</span><span style=\"font-size:11pt;\"> (</span><span style=\"font-size:12.0pt;\">INICET MAY 2022)</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><img src=\"https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/09/07/screenshot-2024-09-07-154211.png\" alt=\"\" width=\"300\" height=\"166\"></span></p>",
    "unique_key": "Q5065369",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066841,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:12.0pt;\"><strong>Ans. C) Adenosine</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">The patient's ECG shows a <strong>regular narrow complex tachycardia</strong>. This type of tachycardia, in a stable patient, is <strong>initially managed with vagal maneuvers such as carotid sinus massage or the Valsalva maneuver.</strong> These maneuvers aim to increase parasympathetic tone and slow conduction through the atrioventricular (AV) node. If vagal maneuvers are ineffective or not feasible, the next step is to administer an AV nodal blocker.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Adenosine is the first-line pharmacological treatment&nbsp;</strong>for stable, regular narrow complex tachycardia. It works by transiently blocking the AV node, thereby interrupting the re-entrant circuit responsible for the tachycardia. The initial dose of adenosine is <strong>6 mg</strong> administered rapidly IV push, followed by a 10 ml saline flush. If the tachycardia persists, additional doses of 12 mg may be given, with a <strong>maximum cumulative dose of 30 mg.</strong> Adenosine has a very short half-life of approximately 8 to 10 seconds, necessitating rapid (IV push) administration and immediate follow-up with normal saline to ensure efficacy.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Other Options:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option A. Amiodarone</strong>: Amiodarone is used for the treatment of various types of arrhythmias, including wide complex tachycardias (regular and monomorphic rhythm).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option B. DC Cardioversion</strong>: Direct current (DC) cardioversion is used in cases of hemodynamic instability or when pharmacological treatment fails. It is not the first-line treatment for a stable patient presenting with regular narrow complex tachycardia.</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Option D. Verapamil</strong>: Verapamil is a calcium channel blocker that can be used to manage atrial fibrillation (irregularly irregular rhythm, because in that case adenosine is contraindicated).</span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\"><strong>Educational Objective:</strong></span></p><p>&nbsp;</p><p><span style=\"font-size:12.0pt;\">For stable, regular narrow complex tachycardia, adenosine is the first-line pharmacological treatment.</span></p>",
    "correct_choice_id": 46376,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "ClinicalVignette",
      "ImageBased",
      "INICET",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  },
  {
    "id": 11702,
    "choices": [
      {
        "id": 46774,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin</span></span></span></span></p>"
      },
      {
        "id": 46775,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Linagliptin</span></span></span></span></p>"
      },
      {
        "id": 46776,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metoprolol </span></span></span></span></p>"
      },
      {
        "id": 46777,
        "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Insulin</span></span></span></span></p>"
      }
    ],
    "text": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Diabetic drug that should be stopped immediately with a creatinine of 5.6mg/dl? (AIIMS NOV 2018)</span></span></span></span></p>",
    "unique_key": "Q7531235",
    "question_audio": null,
    "question_video": null,
    "map_id": 35066857,
    "difficulty_level": "beginner",
    "subjects_id": [
      11
    ],
    "solution": "<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Ans. A) Metformin</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin, a commonly prescribed medication for type 2 diabetes, primarily works by reducing hepatic glucose production. It is contraindicated in patients with significant renal impairment due to the risk of lactic acidosis, a potentially life-threatening condition.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">It is to be stopped if creatinine level &gt;1.5mg/dl in men and &gt;1.4mg/dl in women</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">MOA of metformin- reduces hepatic glucose production.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Adverse effects - nausea, diarrhea, lactic acidosis, vit b12 deficiency</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Contraindications:&nbsp; serum creatinine 1.5 (in males)/ 1.4(females)</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span dir=\"ltr\" lang=\"EN\" style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">GFR&lt;30ml/min, Unstable CHF, Hepatic failure, Acidosis, Hospitalized patients who cannot take anything orally</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Other Options:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option B. Linagliptin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">This is a DPP-4 inhibitor, which does not require adjustment for kidney disease and is not directly harmful in renal failure.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option C. Metoprolol:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">A beta-blocker used for cardiovascular conditions including hypertension; not directly affected by renal function in terms of drug safety, though dosing may need adjustment.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Option D. Insulin:&nbsp;</span></span></strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Often required in higher doses or with careful monitoring in renal impairment due to decreased insulin clearance, but not contraindicated.</span></span></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><strong><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Educational Objective:</span></span></strong></span></span></p>\r\n\r\n<p>&nbsp;</p>\r\n\r\n<p><span style=\"font-size:11pt\"><span style=\"font-family:Arial,sans-serif\"><span style=\"font-size:12.0pt\"><span style=\"font-family:&quot;Calibri&quot;,sans-serif\">Metformin should be discontinued in patients with a creatinine level above 1.5 mg/dL for men and 1.4 mg/dL for women, or a GFR below 30 mL/min to avoid the risk of lactic acidosis, especially in the context of significant renal impairment.</span></span></span></span></p>",
    "correct_choice_id": 46774,
    "solution_audio": null,
    "solution_video": null,
    "audio_explanation_heading": null,
    "video_explanation_heading": null,
    "solution_media_position": "bottom",
    "tags": [
      "AIIMS",
      "Factual",
      "TreatmentBased"
    ],
    "explanation_video": null,
    "question_images": [],
    "explanation_images": []
  }
];
        let quizName = 'Late Night Pyq (Inicet, Medicine-1)';
        const quizFilename = 'late-night-pyq-inicet-medicine-1-2d8e3d3a.html';
        let hierarchy = ["Cerebellum", "Mock Test", "Late Nighgt PYQ (INICET)"];
        
        // Handle Custom Quiz Loading
        if (window.location.pathname.endsWith('custom_quiz.html')) {
            const customData = JSON.parse(localStorage.getItem('customQuizData'));
            if (customData) {
                questionsData = customData.questions;
                quizName = customData.name;
                hierarchy = customData.hierarchy;
                document.title = quizName + ' - Brain And Scalpel';
                document.getElementById('totalQuestions').textContent = questionsData.length;
                document.getElementById('quizHierarchy').textContent = hierarchy.join(' > ');
            }
        }

        let currentQuestionIndex = 0;
        let selectedOption = null;
        let currentMode = 'study';
        let timer = null;
        let timeRemaining = 0;
        let questionStartTime = Date.now();
        let quizStartTime = Date.now();
        let isQuizCompleted = false;
        
        let questionStates = new Array(questionsData.length).fill(null).map(() => ({
            status: 'not_attempted',
            bookmarked: false,
            markedForReview: false,
            selectedAnswer: null,
            timeSpent: 0
        }));
        
        let stats = {
            correctAnswers: 0,
            incorrectAnswers: 0,
            totalAttempted: 0,
            totalTime: 0,
            notAttempted: questionsData.length
        };

        // --- NEW: History Management ---
        function saveProgress() {
            if (isQuizCompleted) return; // Don't save after completion
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            userHistory[quizFilename] = {
                questionStates,
                stats,
                currentQuestionIndex,
                currentMode,
                status: 'incomplete',
                lastSeen: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }

        function loadProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const savedState = userHistory[quizFilename];
            if (savedState) {
                questionStates = savedState.questionStates;
                stats = savedState.stats;
                currentQuestionIndex = savedState.currentQuestionIndex;
                currentMode = savedState.currentMode;
                console.log('Progress loaded.');
                return true;
            }
            return false;
        }

        function clearProgress() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            if(userHistory[quizFilename]) {
                delete userHistory[quizFilename];
                localStorage.setItem('userHistory', JSON.stringify(userHistory));
                console.log('Previous progress cleared.');
            }
        }

        function markQuizAsCompleted() {
            const userHistory = JSON.parse(localStorage.getItem('userHistory')) || {};
            const totalQuestions = questionsData.length;
            const correct = stats.correctAnswers || 0;
            
            userHistory[quizFilename] = {
                score: correct,
                total: totalQuestions,
                status: 'completed',
                completedOn: new Date().toISOString()
            };
            localStorage.setItem('userHistory', JSON.stringify(userHistory));
        }
        // --- End of History Management ---

        const urlParams = new URLSearchParams(window.location.search);
        const startAt = parseInt(urlParams.get('startAt'));
        const resume = urlParams.get('resume') === 'true';

        function goBack() {
            if (!isQuizCompleted) saveProgress(); // Save progress before leaving
            window.location.href = document.referrer || 'index.html';
        }

        function selectMode(mode) {
            currentMode = mode;
            document.getElementById('modeModal').style.display = 'none';
            initializeQuiz();
        }

        function initializeQuiz() {
            quizStartTime = Date.now();
            
            const bookmarkBtn = document.getElementById('bookmarkBtn');
            const markReviewBtn = document.getElementById('markReviewBtn');
            const testModeReviewLegend = document.getElementById('testModeReviewLegend');
            const isTestMode = currentMode === 'test' || currentMode === 'timed_exam';
            
            document.getElementById('statsBar').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('studyModeLegend').style.display = isTestMode ? 'none' : 'block';
            document.getElementById('testModeLegend').style.display = isTestMode ? 'block' : 'none';
            document.getElementById('submitSection').style.display = isTestMode ? 'block' : 'none';
            bookmarkBtn.style.display = isTestMode ? 'none' : 'flex';
            markReviewBtn.style.display = isTestMode ? 'flex' : 'none';
            testModeReviewLegend.style.display = isTestMode ? 'flex' : 'none';
            
            if (currentMode === 'timed_study' || currentMode === 'timed_exam') {
                document.getElementById('timerContainer').classList.remove('hidden');
            }
            
            if (!isNaN(startAt) && startAt >= 0 && startAt < questionsData.length) {
                currentQuestionIndex = startAt;
            }

            loadBookmarkedQuestions();
            generateQuestionNav();
            updateStats();
            displayQuestion();
        }

        function generateQuestionNav() {
            const nav = document.getElementById('questionNav');
            nav.innerHTML = '';
            
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.createElement('button');
                btn.textContent = i + 1;
                btn.className = 'w-8 h-8 text-sm font-medium rounded transition-all duration-200';
                btn.onclick = () => jumpToQuestion(i);
                btn.id = `navBtn_${i}`;
                nav.appendChild(btn);
            }
            
            updateQuestionNav();
        }

        function updateQuestionNav() {
            for (let i = 0; i < questionsData.length; i++) {
                const btn = document.getElementById(`navBtn_${i}`);
                const state = questionStates[i];
                let className = '';
                
                if (i === currentQuestionIndex) {
                    className = 'nav-btn-current';
                } else if (state.bookmarked) {
                    className = 'nav-btn-bookmarked';
                } else if (state.markedForReview) {
                    className = 'nav-btn-marked-review';
                } else if (currentMode === 'study' || currentMode === 'timed_study') {
                    if (state.status === 'correct') className = 'nav-btn-correct';
                    else if (state.status === 'incorrect') className = 'nav-btn-incorrect';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                } else {
                    if (state.selectedAnswer !== null) className = 'nav-btn-answered';
                    else className = 'nav-btn-not-attempted hover:bg-white hover:bg-opacity-20';
                }
                btn.className = `w-8 h-8 text-sm font-medium rounded ${className}`;
            }
        }

        function jumpToQuestion(index) {
            if (index >= 0 && index < questionsData.length) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex = index;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function updateStats() {
            if (currentMode === 'study' || currentMode === 'timed_study') {
                document.getElementById('correctCount').textContent = stats.correctAnswers;
                document.getElementById('incorrectCount').textContent = stats.incorrectAnswers;
                document.getElementById('totalAttempted').textContent = stats.totalAttempted;
                
                const accuracy = stats.totalAttempted > 0 
                    ? Math.round((stats.correctAnswers / stats.totalAttempted) * 100)
                    : 0;
                document.getElementById('accuracy').textContent = accuracy + '%';
                
                stats.totalTime = questionStates.reduce((acc, state) => acc + state.timeSpent, 0);
                const timeSpent = Math.floor(stats.totalTime / 1000);
                const minutes = Math.floor(timeSpent / 60);
                const seconds = timeSpent % 60;
                document.getElementById('timeSpent').textContent = 
                    minutes + ':' + seconds.toString().padStart(2, '0');
            }
        }

        function setupVideo(videoElement, url) {
            if (Hls.isSupported()) {
                const hls = new Hls();
                hls.loadSource(url);
                hls.attachMedia(videoElement);
            } else if (videoElement.canPlayType('application/vnd.apple.mpegurl')) {
                videoElement.src = url;
            }
        }

        function displayQuestion() {
            if (!questionsData || questionsData.length === 0) {
                document.getElementById('questionText').innerHTML = 'No questions available for this quiz.';
                return;
            };
            
            const question = questionsData[currentQuestionIndex];
            questionStartTime = Date.now();
            
            selectedOption = questionStates[currentQuestionIndex].selectedAnswer;
            
            const progress = ((currentQuestionIndex + 1) / questionsData.length) * 100;
            document.getElementById('progressBar').style.width = progress + '%';
            document.getElementById('currentQuestion').textContent = currentQuestionIndex + 1;
            updateQuestionNav();
            
            document.getElementById('prevBtn').disabled = currentQuestionIndex === 0;
            
            document.getElementById('solutionContainer').classList.add('hidden');
            
            document.getElementById('questionText').innerHTML = question.text || 'No question text available';
            
            let mediaHtml = '';
            if (question.question_audio) mediaHtml += `<div class="glass-light p-4 mb-4"><audio src="${question.question_audio}" controls class="w-full"></audio></div>`;
            if (question.question_video) mediaHtml += `<div class="glass-light p-4 mb-4"><video src="${question.question_video}" controls class="w-full rounded-lg"></video></div>`;
            if (question.question_images) {
                question.question_images.forEach(imgSrc => {
                    if (imgSrc) mediaHtml += `<div class="glass-light p-4 mb-4"><img src="${imgSrc}" alt="Question Image" class="w-full rounded-lg"></div>`;
                });
            }
            document.getElementById('questionMedia').innerHTML = mediaHtml;
            
            const optionsContainer = document.getElementById('optionsContainer');
            optionsContainer.innerHTML = '';
            optionsContainer.classList.remove('answered');
            
            if (question.choices && Array.isArray(question.choices)) {
                question.choices.forEach((choice, index) => {
                    const optionLetter = String.fromCharCode(65 + index);
                    const isSelected = selectedOption === index;
                    
                    const optionDiv = document.createElement('div');
                    optionDiv.innerHTML = `
                        <button type="button" class="option-button ${isSelected ? 'selected' : ''}" data-option-index="${index}">
                            <div class="option-letter">${optionLetter}</div>
                            <div class="option-text">${choice.text || 'Option ' + (index + 1)}</div>
                        </button>
                    `;
                    optionsContainer.appendChild(optionDiv);
                });
                
                optionsContainer.addEventListener('click', function(e) {
                    const optionButton = e.target.closest('.option-button');
                    if (optionButton) {
                        const optionIndex = parseInt(optionButton.getAttribute('data-option-index'));
                        selectOption(optionIndex);
                    }
                });
            }
            
            updateBookmarkButton();
            updateMarkReviewButton();

            if ((currentMode === 'timed_study' || currentMode === 'timed_exam') && !isQuizCompleted) {
                startTimer();
            }
        }

        function selectOption(index) {
            const optionsContainer = document.getElementById('optionsContainer');
            if (optionsContainer.classList.contains('answered')) return;

            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                questionStartTime = Date.now();
            }
            
            selectedOption = index;
            questionStates[currentQuestionIndex].selectedAnswer = index;
            
            document.querySelectorAll('.option-button').forEach((btn, i) => {
                btn.classList.toggle('selected', i === index);
            });
            
            if (currentMode === 'study' || currentMode === 'timed_study') {
                processAnswer();
            } else {
                if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                    questionStates[currentQuestionIndex].status = 'answered';
                    stats.totalAttempted++;
                    stats.notAttempted--;
                }
                updateQuestionNav();
            }
            saveProgress(); // NEW: Save on answer selection
        }

        function processAnswer() {
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            
            if(selectedOption === null) return;

            const selectedChoice = question.choices[selectedOption];
            const isCorrect = selectedChoice.id === correctChoiceId;
            
            if (questionStates[currentQuestionIndex].status === 'not_attempted') {
                stats.totalAttempted++;
                stats.notAttempted--;
                if(isCorrect) stats.correctAnswers++; else stats.incorrectAnswers++;
            }
            questionStates[currentQuestionIndex].status = isCorrect ? 'correct' : 'incorrect';
            
            updateStats();
            showInlineFeedback(isCorrect);
            updateQuestionNav();
        }

        function showInlineFeedback(isCorrect) {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;

            const optionsContainer = document.getElementById('optionsContainer');
            const optionButtons = optionsContainer.querySelectorAll('.option-button');
            const question = questionsData[currentQuestionIndex];
            const correctChoiceId = question.correct_choice_id;
            let correctOptionIndex = question.choices.findIndex(c => c.id === correctChoiceId);

            optionsContainer.classList.add('answered');

            optionButtons.forEach((btn, index) => {
                btn.classList.remove('selected');
                if (index === correctOptionIndex) btn.classList.add('correct');
                else if (index === selectedOption && !isCorrect) btn.classList.add('incorrect');
            });

            showSolution();
        }


        function showSolution() {
            if (currentMode !== 'study' && currentMode !== 'timed_study') return;
            
            const question = questionsData[currentQuestionIndex];
            document.getElementById('solutionText').innerHTML = question.solution || 'No solution provided';
            
            const videoContainer = document.getElementById('solutionVideo');
            const videoPlayer = document.getElementById('explanationVideoPlayer');
            const explanationVideo = question.explanation_video;
            
            if (explanationVideo) {
                videoContainer.classList.remove('hidden');
                if (explanationVideo.includes('.m3u8')) setupVideo(videoPlayer, explanationVideo);
                else videoPlayer.src = explanationVideo;
            } else {
                videoContainer.classList.add('hidden');
            }

            const audioContainer = document.getElementById('solutionAudio');
            audioContainer.innerHTML = '';
            if (question.explanation_audio_eng) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English Explanation:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
            }
            if (question.explanation_audio_hin) {
                audioContainer.innerHTML += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish Explanation:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;
            }
            
            const imagesContainer = document.getElementById('solutionImages');
            imagesContainer.innerHTML = '';
            if (question.explanation_images) {
                 question.explanation_images.forEach(imgSrc => {
                    if(imgSrc) imagesContainer.innerHTML += `<div class="mt-4"><img src="${imgSrc}" alt="Explanation Image" class="w-full rounded-lg"></div>`;
                });
            }

            document.getElementById('solutionContainer').classList.remove('hidden');
        }

        function submitQuiz() {
            if (timer) clearInterval(timer);
            if (!confirm('Are you sure you want to submit the quiz?')) return;
            
            isQuizCompleted = true;
            let correct = 0, incorrect = 0;
            const totalTime = Date.now() - quizStartTime;
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                if (state.selectedAnswer !== null) {
                    if (question.choices[state.selectedAnswer].id === question.correct_choice_id) {
                        correct++;
                        state.status = 'correct';
                    } else {
                        incorrect++;
                        state.status = 'incorrect';
                    }
                }
            });
            
            // Save performance data
            const performanceData = JSON.parse(localStorage.getItem('quizPerformanceData')) || [];
            performanceData.push({
                quizName: quizName,
                hierarchy: hierarchy,
                timestamp: Date.now(),
                totalTime: totalTime,
                stats: {
                    correct: correct,
                    incorrect: incorrect,
                    notAttempted: questionsData.length - (correct + incorrect)
                }
            });
            localStorage.setItem('quizPerformanceData', JSON.stringify(performanceData));

            stats.correctAnswers = correct; // Update global stats
            stats.incorrectAnswers = incorrect;
            markQuizAsCompleted(); // NEW: Mark quiz as complete in history
            showPerformanceAnalysis(correct, incorrect, questionsData.length - (correct + incorrect), totalTime);
        }

        function showPerformanceAnalysis(correct, incorrect, notAttempted, totalTime) {
            const modal = document.getElementById('performanceModal');
            const accuracy = (correct + incorrect) > 0 ? Math.round((correct / (correct + incorrect)) * 100) : 0;
            
            const circumference = 2 * Math.PI * 65;
            const scoreCircle = document.getElementById('scoreCircle');
            scoreCircle.style.strokeDasharray = `${circumference} ${circumference}`;
            scoreCircle.style.strokeDashoffset = circumference - (accuracy / 100) * circumference;
            
            document.getElementById('accuracyScore').textContent = `${accuracy}%`;
            document.getElementById('totalQuestionsResult').textContent = questionsData.length;
            document.getElementById('correctResult').textContent = correct;
            document.getElementById('incorrectResult').textContent = incorrect;
            document.getElementById('notAttemptedResult').textContent = notAttempted;
            
            const totalMinutes = Math.floor(totalTime / 60000);
            const totalSeconds = Math.floor((totalTime % 60000) / 1000);
            document.getElementById('totalTimeResult').textContent = `${totalMinutes}:${totalSeconds.toString().padStart(2, '0')}`;
            
            const avgTime = totalTime / questionsData.length;
            const avgMinutes = Math.floor(avgTime / 60000);
            const avgSeconds = Math.floor((avgTime % 60000) / 1000);
            document.getElementById('avgTimeResult').textContent = `${avgMinutes}:${avgSeconds.toString().padStart(2, '0')}`;
            
            modal.classList.remove('hidden');
        }

        function closePerformanceModal() { document.getElementById('performanceModal').classList.add('hidden'); }

        function reviewQuestions() {
            document.getElementById('questionReviewSection').classList.remove('hidden');
            const container = document.getElementById('reviewQuestionsContainer');
            container.innerHTML = '';
            
            questionsData.forEach((question, index) => {
                const state = questionStates[index];
                const correctChoiceId = question.correct_choice_id;
                
                let statusClass = 'not-attempted', statusText = 'Not Attempted';
                if (state.selectedAnswer !== null) {
                    const selectedChoice = question.choices[state.selectedAnswer];
                    if (selectedChoice.id === correctChoiceId) { statusClass = 'correct'; statusText = 'Correct'; }
                     else { statusClass = 'incorrect'; statusText = 'Incorrect'; }
                }
                
                const reviewDiv = document.createElement('div');
                reviewDiv.className = `review-question ${statusClass}`;
                
                let optionsHtml = (question.choices || []).map((choice, choiceIndex) => {
                    const isSelected = state.selectedAnswer === choiceIndex;
                    const isCorrect = choice.id === correctChoiceId;
                    let borderClass = 'border-gray-600';
                    if(isCorrect) borderClass = 'border-green-500';
                    else if(isSelected) borderClass = 'border-red-500';
                    
                    return `<div class="p-3 rounded-lg border ${borderClass}"><span class="font-bold mr-3">${String.fromCharCode(65 + choiceIndex)}</span><span>${choice.text}</span></div>`;
                }).join('');

                const videoHtml = question.explanation_video ? `<div class="mt-4"><video id="review-video-${index}" data-src="${question.explanation_video}" class="w-full rounded-lg" controls></video></div>` : '';
                
                let audioHtml = '';
                if(question.explanation_audio_eng) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">English:</p><audio src="${question.explanation_audio_eng}" controls class="w-full"></audio></div>`;
                if(question.explanation_audio_hin) audioHtml += `<div class="mt-2"><p class="text-sm text-white text-opacity-70 mb-1">Hinglish:</p><audio src="${question.explanation_audio_hin}" controls class="w-full"></audio></div>`;

                let imagesHtml = (question.explanation_images || []).map(src => src ? `<div class="mt-4"><img src="${src}" alt="Explanation Image" class="w-full rounded-lg"></div>` : '').join('');

                reviewDiv.innerHTML = `
                    <div class="mb-4">
                        <div class="flex justify-between items-center mb-3">
                            <h4 class="text-lg font-bold text-white">Question ${index + 1}</h4>
                            <span class="text-sm px-3 py-1 rounded-full bg-${statusClass === 'correct' ? 'green' : statusClass === 'incorrect' ? 'red' : 'gray'}-600 text-white">${statusText}</span>
                        </div>
                        <div class="text-white mb-4">${question.text}</div>
                    </div>
                    <div class="space-y-2 mb-4">${optionsHtml}</div>
                    <div class="bg-green-900 bg-opacity-20 p-4 rounded-lg border border-green-700">
                        <h5 class="text-green-400 font-bold mb-2">Explanation:</h5>
                        <div class="text-white text-opacity-90">${question.solution || 'No solution available.'}</div>
                        ${videoHtml}
                        ${audioHtml}
                        ${imagesHtml}
                    </div>`;
                container.appendChild(reviewDiv);
            });
            initializeReviewVideos();
        }

        function initializeReviewVideos() {
            document.querySelectorAll('video[data-src]').forEach(videoEl => {
                const src = videoEl.dataset.src;
                if (src && src.includes('.m3u8')) {
                    setupVideo(videoEl, src);
                } else if (src) {
                    videoEl.src = src;
                }
            });
        }

        function retakeQuiz() {
            if (confirm('Are you sure you want to retake the quiz? This will reset all your answers.')) {
                if (window.location.pathname.endsWith('custom_quiz.html')) {
                    localStorage.removeItem('customQuizData');
                }
                clearProgress(); // NEW: Clear history on retake
                location.reload();
            }
        }

        function loadBookmarkedQuestions() {
            const bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            bookmarks.forEach(bookmark => {
                if (bookmark.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-'))) {
                    if (bookmark.questionIndex < questionsData.length) {
                        questionStates[bookmark.questionIndex].bookmarked = true;
                    }
                }
            });
        }

        function toggleBookmark() {
            const isBookmarked = !questionStates[currentQuestionIndex].bookmarked;
            questionStates[currentQuestionIndex].bookmarked = isBookmarked;
            
            let bookmarks = JSON.parse(localStorage.getItem('bookmarkedQuestions')) || [];
            
            if (isBookmarked) {
                const bookmarkData = {
                    quizName: quizName,
                    quizFile: window.location.pathname.split('/').pop(),
                    questionIndex: currentQuestionIndex,
                    question: questionsData[currentQuestionIndex],
                    hierarchy: hierarchy,
                    timestamp: Date.now()
                };
                bookmarks.push(bookmarkData);
            } else {
                bookmarks = bookmarks.filter(b => 
                    !(b.quizFile.includes(quizName.toLowerCase().replace(/ /g, '-')) && b.questionIndex === currentQuestionIndex)
                );
            }
            
            localStorage.setItem('bookmarkedQuestions', JSON.stringify(bookmarks));
            updateBookmarkButton();
            updateQuestionNav();
        }

        function updateBookmarkButton() {
            const btn = document.getElementById('bookmarkBtn');
            const text = document.getElementById('bookmarkText');
            const isBookmarked = questionStates[currentQuestionIndex].bookmarked;
            
            btn.className = isBookmarked ? 'gradient-yellow px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-yellow-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isBookmarked ? 'Bookmarked' : 'Bookmark';
        }
        
        function toggleMarkForReview() {
            questionStates[currentQuestionIndex].markedForReview = !questionStates[currentQuestionIndex].markedForReview;
            updateMarkReviewButton();
            updateQuestionNav();
        }

        function updateMarkReviewButton() {
            const btn = document.getElementById('markReviewBtn');
            const text = document.getElementById('markReviewText');
            const isMarked = questionStates[currentQuestionIndex].markedForReview;
            
            btn.className = isMarked ? 'gradient-purple px-6 py-3 text-white transition-all duration-300 flex items-center' : 'glass-light px-6 py-3 text-white hover:bg-purple-500 hover:bg-opacity-20 transition-all duration-300 flex items-center';
            text.textContent = isMarked ? 'Marked' : 'Mark for Review';
        }

        function previousQuestion() {
            if (currentQuestionIndex > 0) {
                if (questionStartTime) {
                    questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
                }
                
                currentQuestionIndex--;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            }
        }

        function nextQuestion() {
            if (questionStartTime) {
                questionStates[currentQuestionIndex].timeSpent += Date.now() - questionStartTime;
            }
            
            if (currentQuestionIndex < questionsData.length - 1) {
                currentQuestionIndex++;
                displayQuestion();
                saveProgress(); // NEW: Save on navigation
            } else {
                if (currentMode === 'test' || currentMode === 'timed_exam') {
                    if (confirm('You have reached the end of the quiz. Would you like to submit your answers now?')) {
                        submitQuiz();
                    }
                } else {
                    if (confirm('You have completed all questions. Would you like to review from the beginning?')) {
                        currentQuestionIndex = 0;
                        displayQuestion();
                        saveProgress();
                    }
                }
            }
        }

        function startTimer() {
            if (timer) clearInterval(timer);
            timeRemaining = 120; // 2 minutes per question
            updateTimerDisplay();
            
            timer = setInterval(() => {
                timeRemaining--;
                updateTimerDisplay();
                
                if (timeRemaining <= 0) {
                    clearInterval(timer);
                    if (currentMode === 'timed_exam') {
                        submitQuiz();
                    } else {
                        nextQuestion();
                    }
                }
            }, 1000);
        }

        function updateTimerDisplay() {
            const minutes = Math.floor(timeRemaining / 60);
            const seconds = timeRemaining % 60;
            document.getElementById('timeDisplay').textContent = 
                minutes + ':' + seconds.toString().padStart(2, '0');
        }

        function toggleSidebar() {
            document.getElementById('quizSidebar').classList.toggle('open');
        }

        document.addEventListener('DOMContentLoaded', () => {
             if (resume) {
                if (loadProgress()) {
                    document.getElementById('modeModal').style.display = 'none';
                    initializeQuiz(); // Resume directly into the saved mode and state
                } else {
                    // If resume fails (e.g., cleared history), start fresh
                    clearProgress();
                    document.getElementById('modeModal').style.display = 'flex';
                }
             } else if (!window.location.pathname.endsWith('custom_quiz.html')) {
                clearProgress(); // Clear old progress if not resuming
                document.getElementById('modeModal').style.display = 'flex';
             } else {
                initializeQuiz();
             }
        });
        
        document.addEventListener('keydown', function(e) {
            if (document.getElementById('modeModal').style.display !== 'none') return;
            if (document.getElementById('performanceModal').classList.contains('hidden') === false) return;
            
            if (e.key >= '1' && e.key <= '4') {
                const optionIndex = parseInt(e.key) - 1;
                const options = document.querySelectorAll('.option-button');
                if (optionIndex < options.length) selectOption(optionIndex);
            } else if (e.key === 'ArrowLeft') {
                previousQuestion();
            } else if (e.key === 'ArrowRight' || e.key === ' ') {
                e.preventDefault();
                nextQuestion();
            } else if (e.key.toLowerCase() === 'b' && (currentMode === 'study' || currentMode === 'timed_study')) {
                toggleBookmark();
            } else if (e.key.toLowerCase() === 'm' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                toggleMarkForReview();
            } else if (e.key.toLowerCase() === 's' && (currentMode === 'test' || currentMode === 'timed_exam')) {
                submitQuiz();
            }
        });
    </script>
</body>
</html>